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 Obesity is rapidly increasing worldwide among all age groups. Insulin resistance 
or type 2 diabetes is one of several debilitating health problems associated with obesity. 
An emerging feature of obesity and type 2 diabetes is their linkage with chronic, low-
grade inflammation that begins in white adipose tissue (WAT) and eventually becomes 
systemic. One potential dietary strategy to reduce chronic inflammation is consumption 
of fruits and vegetables rich in polyphenols, including grape products, which possess 
anti-oxidant and anti-inflammatory properties. Notably, several clinical and animal 
studies have shown that supplementation with grape products like grape juice, grape 
powder or extracts, and red wine reduced oxidative damage and inflammation. However, 
the suppressive effects of grape powder on adipocyte-derived inflammation and insulin 
resistance remains uncertain. Additionally, the bioavailability of grape polyphenols and 
their ability to lower inflammation and insulin resistance in vitro and in a diet-induced 
obese animal model are unclear.  
Therefore, the specific aims of this research were to determine the extent to which 
1) grape powder extract (GPE) and several of its polyphenols decrease tumor necrosis 
factor alpha (TNFα)-mediated inflammation and insulin resistance and their mechanisms 
of action in primary cultures of human adipocytes (Aim 1), and 2) grape powder 
polyphenols are absorbed and reduce markers of inflammation and insulin resistance in 
high fat-fed obese mice (Aim 2). In Aim 1, GPE and quercetin, an abundant polyphenol 
 
in GPE, attenuated TNFα-induced a) expression of inflammatory genes, b) activ tion of 
inflammatory mitogen-activated protein kinases (MAPKs) and transcription factors 
nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1), c) expression or 
abundance of two negative regulators of insulin sensitivity, and d) suppression of insulin-
stimulated glucose uptake. Taken together, these data emonstrate that GPE and 
quercetin attenuate TNFα-mediated inflammation and insulin resistance in prima y 
cultures of human adipocytes, possibly by suppressing the activation of inflammatory 
MAPKs and transcription factors that cause insulin resistance. In Aim 2, it was found that 
a) quercetin 3-O-glucoside was one of the most abundant polyphenols detected in the sera 
of mice gavaged with GPE, b) high fat-fed mice supplemented with quercetin-rich grape 
powder had improved glucose disposal rates acutely and reduced markers of 
inflammation in the sera and WAT chronically, and c) quercetin 3-O-glucoside reduced 
several markers of inflammation in primary cultures of human adipocytes. Collectively, 
these findings are expected to contribute critical insights for the development of dietary 
strategies using grape products for the control of obesity-related conditions including 
inflammation and insulin resistance or type 2 diabetes. However, clinical trials are needed 
to determine the extent to which these findings can be reproduced in humans. 
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CHAPTER I 
 
INTRODUCTION 
 
 
Overview 
Obesity is the most prevalent nutrition-related healt  problem worldwide, with 1.5 
billion adults and 43 million children under the age of five classified as overweight and 
more than 500 million people classified as obese (1). Obesity is caused by a positive 
energy balance due to overconsumption of calories relative to energy expenditure that 
leads to the expansion of white adipose tissue (WAT) mass. Enlarged WAT is associated 
with a progressive infiltration and accumulation of macrophages that contribute to a 
chronic, low grade inflammation characterized by increased pro-inflammatory cytokines 
such as tumor necrosis factor alpha (TNFα; 2) or interleukin-6 (IL-6; 3) and chemokines 
such as monocyte chemoattractant protein-1 (MCP-1; 4). These inflammatory adipokines 
that activate mitogen-activated protein kinase (MAPK) signaling pathways, including 
extracellular signal-related kinase (ERK) or c-Jun-NH2 terminal kinase (JNK) and their 
downstream transcription factor nuclear factor-kappa B (NF-κB) or activator protein-1 
(AP-1), respectively, involve in the development of obesity-mediated insulin resistance or 
type 2 diabetes (Reviewed in 5, 6).  
Polyphenol-rich grapes are one of the most widely consumed fruits in the world. 
Early epidemiologic research reported that consumption of red wine correlated with a 
lower risk of cardiovascular diseases, referred to as the “Fr nch Paradox” (7, 8). Recent
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studies have demonstrated cardioprotective effects of grapes and their by-products (e.g., 
red wine, grape juice, powder, and extracts) due to their abundant content of polyphenols 
(e.g., quercetin and resveratrol), which possess anti-oxidant and anti-inflammatory 
properties (reviewed in 9, 10). However, the inhibitory effect of grapes and their 
polyphenols on obesity-mediated inflammation and insuli  resistance remains uncertain. 
Specifically, the ability of grape polyphenols to attenuate inflammation and insulin 
resistance triggered by TNFα and their mechanisms of action in primary human 
adipocytes are unknown. Additionally, the bioavailability of grape polyphenols and their 
ability to reduce inflammation and insulin resistance in a diet-induced obese animal 
model are unclear. Elucidating these questions will provide valuable information for the 
development of dietary strategies for the control of obesity-associated inflammation and 
insulin resistance. 
 
Central Hypothesis and Specific Objectives 
 The central hypothesis for the proposed research is t at 1) grape powder extract 
(GPE) and two of its polyphenols, quercetin and resveratrol, attenuate TNFα-mediated 
inflammation and insulin resistance, possibly by suppressing the activation of MAPKs 
(i.e., ERK and JNK), NF-κB, and AP-1, in primary human adipocyte cultures, and 2) 
several grape powder polyphenols are bioavailable in mice, and improve glucose disposal 
rates and reduce markers of chronic inflammation in high fat-fed obese mice. 
 In order to test this hypothesis, the following two specific aims were investigated: 
Aim 1) determine the extent to which GPE and several of its polyphenols decrease 
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TNFα-mediated inflammation and insulin resistance and their mechanisms of action in 
primary cultures of human adipocytes, and Aim 2) determine the extent to which grape 
powder polyphenols are absorbed and reduce markers of inflammation and insulin 
resistance in high fat-fed obese mice.   
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CHAPTER II 
 
REVIEW OF LITERATURE 
 
 
Background and Significance 
 
Obesity, Inflammation, and Metabolic Diseases  
Factors Influencing White Adipose Tissue Growth, Development, and Overexpansion that 
Lead to Obesity  
Obesity is a global health issue, with more than 500 million people classified as 
obese and 1.5 billion overweight, including 43 million children under the age of five 
(http://www.who.int/mediacentre/factsheets/fs311/en/index.html). In the United States, 
obesity is rapidly increasing among all age groups. Currently, in all but two states at least 
20% of the population is classified as obese (http://www.cdc.gov/obesity/data/trends.html) 
Diets high in calories, especially from sugars, saturated fatty acids (SFAs), and long-
chain omega-6 polyunsaturated fatty acids (PUFAs), and sedentary lifestyles lacking 
physical activity contribute significantly to this obesity epidemic. Endogenous and 
exogenous factors that enhance preadipocyte proliferation or adipocyte hypertrophy have 
the capacity to increase white adipose tissue (WAT) mass and the development of obesity 
(reviewed in 66, 116). 
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Metabolic Consequences of Expanding White Adipose Tissue and Its Impact on Liver, 
Muscle, and Pancreas 
The rapid rise in obesity is accompanied by a similar increase in cardiovascular 
disease (CVD), hypertension, and insulin resistance or type 2 diabetes (http:// 
www.who.int/mediacentre/factsheets/fs311/en/index.html). For instance, ∼80% of people 
with type 2 diabetes are overweight or obese (13), suggesting a strong positive 
relationship between the two diseases (http://www.cdc.gov/nccdphp/dnpa/obesity/ 
consequences.htm). Obese patients with type 2 diabetes have elevated levels of tumor 
necrosis factor alpha (TNFα) in their blood (133), WAT (50), and muscle (97). 
Furthermore, impaired glucose disposal is positively correlated to TNFα expression (97, 
104, 133). Metabolic endotoxemia [e.g., elevated lipopolysaccharide (LPS) level in 
circulation] is also associated with obesity (14). 
This cluster of obesity-related, metabolic diseases i  known as the metabolic 
syndrome. One emerging feature of the metabolic syndrome is its linkage with chronic 
inflammation in WAT that becomes systemic. It is characterized by engorged adipocyte 
death (107), increased cytokine/chemokine production and inflammatory signaling, and 
recruitment of leukocytes (reviewed in 48). Thus, excess WAT is an overactive endocrine 
organ secreting an array of inflammatory adipokines that contribute to the metabolic 
syndrome (reviewed in 44). Furthermore, as WAT mass increases, its lipid- and glucose-
buffering capacity decreases. This results in elevated blood levels of free fatty acids 
(FFAs), very-low-density lipoprotein (VLDL) (hyperlipidemia), glucose (hyperglycemia), 
and insulin (hyperinsulinemia), as well as ectopic lipid accumulation in skeletal and 
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cardiac muscle, liver (steatosis), and pancreas (Figure 2.1). Understanding the mediators 
of this inflammation and their mechanisms of action s essential in order to develop 
effective strategies to prevent chronic inflammatory signaling from WAT. 
 
Pro-inflammatory Role of Free Fatty Acids and Adipokines 
Free fatty acids, especially SFAs, contribute signif cantly to chronic inflammation 
(reviewed in 58). For example, palmitate activates protein kinase C (PKC) signaling, 
generates ceramide and reactive oxygen species (ROS), and increases oxidative or 
endoplasmic reticulum (ER) stress, all of which are ssociated with chronic inflammation 
or insulin resistance. Dietary constituents like SFA may also alter gut microflora, leading 
to elevated blood levels of LPS or TNFα that cause endotoxemia (14). 
Tumor necrosis factor alpha, LPS, SFA, or FFA instigate inflammation and 
insulin resistance by triggering ROS-mediated oxidative or ER stress and serine/threonine 
kinase phosphorylation signaling that active inflammatory mitogen-activated protein 
kinases (MAPKs), including extracellular signal-relat d kinase (ERK) and c-Jun-NH2-
terminal kinase ( JNK), IκBα kinase (IKK), and transcription factors nuclear factor-kappa 
B (NF-κB) and activating protein (AP)-1 (reviewed in 45). Collectively, these proteins 
induce inflammatory gene transcription, antagonize peroxisome proliferator-activated 
receptor gamma (PPARγ) activity, or directly impair insulin receptor substrate (IRS)-1 
signaling, leading to insulin resistance. Furthermore, engorged adipocytes release 
chemokines such as monocyte chemoattractant protein (MCP)-1 that attract monocytes 
and stimulate their recruitment and differentiation i to macrophages (MΦ) via 
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chemotaxis (reviewed in 77). Monocyte chemoattractant protein-1 has also been reported 
to convert alternatively activated MΦ (M2) into classically activated MΦ (M1), further 
increasing inflammation and insulin resistance (Figure 2.2). Such an inflammatory 
scenario in perivascular WAT can lead to plaque formation and smooth muscle migration 
and proliferation in the vascular endothelium and wall, thereby increasing the 
development of CVD (reviewed in 95). 
Thus, a positive energy balance expands WAT, generati g dipokines such as 
TNFα and MCP-1 as well as FFA that recruit and activate MΦ and activate inflammatory 
cascades. These responses antagonize PPARγ activity, leading to decreased glucose and 
FA uptake and metabolism, causing ectopic lipid accumulation (lipodystrophy), 
hyperglycemia, and hyperlipidemia. Proposed mechanisms by which these inflammatory 
signals reduce PPARγ activity include (a) decreased PPARγ mRNA levels, (b) increased 
phosphorylation of serine residue 112 of PPARγ by ERK, leading to PPARγ ubiquination 
and proteosome degradation, (c) decreased PPARγ DNA binding, and (d) decreased 
PPARγ transcriptional activity (Figure 2.3) (reviewed in 129). Discovery of dietary 
strategies, including the consumption of polyphenol-rich grapes or grape products, to 
reduce obesity-related chronic inflammation could potentially attenuate metabolic 
diseases. 
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Types and Abundance of Phenolic Phytochemicals in Grapes 
Types of Phenolic Phytochemicals in Grapes and Grape Products 
Grapes and their by-products are consumed worldwide. Th re are more than 50 
varieties of seeded and seedless grapes in black, blue lue-black, golden, red, green, 
purple, and white colors. Common grape products include table grapes, wine, raisins, 
juices, and preservatives. The average annual consumption of fresh grapes in the United 
States is about eight pounds per person (http://www.ers.usda.gov/Data/FoodConsumption) 
Most of the grapes consumed in the United States ar grown in California. Table grapes 
contain essential nutrients such as water, carbohydrates, proteins, fats, vitamins, minerals, 
and fiber (reviewed in 127) and nonessential compounds including phytochemicals. 
Phenolic phytochemicals in grapes (Table 2.1) possess biological activities that have 
been reported to promote health (reviewed in 125). Some of the early health benefits of 
consuming red wine (e.g., decreased the risk of CVD), referred to as the “French Paradox” 
(92, 103), have been attributed to its phenolic phytochemicals including resveratrol. 
Ironically, the resveratrol content of grapes and re wine is relatively low compared to 
other polyphenols (Table 2.1).  
The predominant phenolic phytochemicals in grapes are flavonoids such as 
flavonols, flavan-3-ols (monomers, oligomers, or polymers), and anthocyanidins/ 
anthocyanins, and to a much lesser extent nonflavonoids such as stilbenes, phenolic 
acids/hydroxybenzoates, and hydroxycinnamates (Tables 2.1 and 2.2; 15, 17, 18, 29, 30, 
41, 43, 56, 71, 78, 84, 85, 88, 90). Quercetin is the major flavonol in grapes (Figure 2.4A) 
and usually occurs as O-glucosides in the D-glucose isoform such as quercetin 3-O-
10 
 
glucoside (Figure 2.4B). Grape flavan-3-ols are mainly represented by monomeric 
catechins such as (+)-catechin (Figure 2.4C) and oligomeric procyanidins, also known as 
proanthocyanidins or condensed tannins, such as procyanidin B2 (Figure 2.4D). 
Anthocyanins (i.e., anthocyanidins with sugar groups) in grapes are primarily 3-O
glucosides such as malvidin (Figure 2.4E) and malvidin 3-O-glucoside (Figure 2.4F), 
which are found in red grapes. Trans-resveratrol (Figure 2.4G) is probably the most 
well-known and studied stilbene found in grapes andre  wine. Phenolic acids, also 
known as hydroxybenzoates, are commonly represented by gallic acid (Figure 2.4H) in 
grapes. In grapes or grape products, hydroxycinnamates usually undergo esterification 
with tartaric acid such as caffeic acids (Figure 2.4I) and its tartaric acid esters such as 
caftaric acid (Figure 2.4J). 
The phenolic phytochemical content of grapes varies due to grape type, color, and 
ripeness, and climatic, geographical, and cultural factors. In general, flavonols and 
anthocyanidins/anthocyanins represent colored phenols and flavan-3-ols, phenolic 
acids/hydroxybenzoates, and hydroxycinnamates repres nt noncolored phenols in grapes 
or grape products (Table 2.2). These polyphenols are present mainly in skins and seeds 
and contribute to the astringency, bitterness, and color of the grapes and wine. 
Polyphenols also impact the quality of the wine produced and potential health benefits 
associated with wine consumption. 
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Relatively High Abundance of Anthocyanidins/Anthocyanins and Flavonols in Grapes 
Grapes are particularly rich in anthocyanidins/anthocyanins (e.g., malvidin, 
cyanidin, and peonidin) and to a lesser extent flavonols (e.g., quercetin) (Tables 2.1 and 
2.2). The average of daily anthocyanidin/anthocyanin ad flavonol intake from all foods 
in the United States is approximately 12.5 mg (124) and 20.0 mg (68, 99) per person, 
respectively. Average adult plasma levels of flavonols such as quercetin and isorhamnetin, 
a metabolite of quercetin, are approximately 53.9 nM and 3.0 nM, respectively (34). 
However, anthocyanidins/anthocyanins such as malvidin 3-O-glucoside were 
undetectable in the plasma of adult subjects (12, 40). Also, variation in plasma levels of 
polyphenols or their metabolites between individuals is high at baseline and after 
intervention (34, 75).  
The bioavailability of these anthocyanidins/anthocyanins and flavonols has been 
reported to be poor based on in vitro (11, 30, 37, 1 0) and in vivo studies (reviewed in 32, 
96). However, phenolic phytochemicals may be rapidly metabolized by cells and 
therefore difficult to detect within the circulation or cells following consumption or 
supplementation (105). Also, despite having relatively low abundance and poor 
bioavailability, some polyphenols have potent biological actions (i.e., resveratrol; 5, 6, 
62). Because of the relative high abundance and biological activity of grape 
anthocyanidins/anthocyanins and flavonols, the following sections focus on potential 
mechanisms by which they reduce chronic inflammation associated with obesity and 
related metabolic diseases. 
 
12 
 
Mechanisms by Which Anthocyanidins/Anthocyanins and Flavonols, Major 
Phenolic Phytochemicals in Grapes, Reduce Chronic Inflammation 
Acting as an Antioxidant or Increasing Antioxidant Gene or Protein Expression 
Reactive oxygen species and reactive nitrogen species (RNS) can be generated by 
enzyme systems such as nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 
and nitric oxide synthase (NOS), respectively, or transition metals, and are notorious 
mediators of oxidative stress and inflammation. Reactive oxygen species trigger redox-
sensitive kinases such as apoptosis signal-regulating k nase 1 (ASK1) that activate 
downstream MAPKs, NF-κB, and AP-1, which in turn induce inflammatory gene 
expression. Phenolic phytochemicals have a strong antioxidant potential owing to the 
abundance of hydroxyl groups associated with their aromatic rings. Phenolic 
phytochemicals also have the capacity to increase the levels of anti-inflammatory genes 
such as superoxide dismutase (SOD), glutathione peroxidase (GPx), and heme oxygenase 
(HO)-1 via activation of the transcription factor nuclear factor-erythroid 2 (NF-E2)-
related factor 2 (Nrf2) (reviewed in 91). Thus, polyphenols have an inherent capacity to 
reduce ROS and other free radicals, thereby preventing their activation of oxidative stress 
and inflammation. Consistent with this antioxidant potential, Sprague-Dawley rats 
consuming a high-fructose diet supplemented with a grape skin extract (21 mg/kg body 
weight for six weeks) were protected against ROS production, possibly due to reduced 
levels of NADPH oxidase, thereby preventing cardiac hypertrophy and hypertension 
induced by a high-fructose diet (2).  
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In vitro, pretreatment with freeze-dried grape powder (300 µg/ml) restored 
glutathione (GSH) content in human hepatoma cells (Huh7 cells) and primary mouse 
hepatocytes treated with hydrogen peroxide (H2O2) (1 6). The flavonols quercetin and 
kaempferol (5-50 µM) decreased the levels of oxidized GSH, peroxides, superoxide 
anions, and nitric oxide in parenchymal liver cells (Chang liver cells) treated with a 
mixture of inflammatory cytokines (28). Quercetin pretreatment (25 µM) of primary 
cultures of rat neurons exposed to H2O2 increased GSH levels, the nuclear translocation 
of Nrf2, and the expression of γ-glutamate-cysteine ligase catalytic subunit (GCLC), the 
rate-limiting enzyme for GSH synthesis, compared with those treated with H2O2 only (3). 
However, cells treated with doses of quercetin higher t an 25 µM for 24 hours showed 
signs of cytotoxicity. 
Quercetin and isorhamnetin (10 µM) pretreatment of murine macrophages 
(RAW264.7 cells) treated with LPS decreased the expression of inflammatory genes and 
inducible NOS and increased the protein levels of HO-1 (10). However, cells treated with 
doses of these flavonols equal to or greater than 25 µM for 24 hours showed signs of 
cytotoxicity. Quercetin pretreatment (10-50 µM) of immortalized human keratinocytes 
(HaCaT cells) treated with H2O2 increased mitochondrial membrane potential and cell 
viability and reduced the percentage of apoptotic cells compared with controls (122). 
Quercetin pretreatment (10 and 100 µM) of human hepatoma cells treated with H2O2 or 
CuSO4 (to initiate the Fenton reaction for the production of hydroxyl radicals) acutely 
decreased ROS production (60). However, long term treatment with high levels of 
quercetin (100 µM) decreased cell viability, suggesting pro-oxidant c ions of quercetin 
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at high levels. Pretreatment with the anthocyanin cyanidin 3-glucoside (10-40 µM) of 
murine adipocytes (3T3-L1 cells) exposed to H2O2 or TNFα decreased ROS production 
and insulin resistance compared with controls (46). Quercetin and rutin (1-25 µM), a 
quercetin metabolite, blocked oxidized low-density lipoprotein (LDL)-mediated 
apoptosis of human umbilical vein endothelial cells via modulation of Janus kinase/signal 
transducers and activators of the transcription sigal ng pathway (23). Rutin, but not 
quercetin, inhibited JNK and p38 signaling by decreasing the activation of ASK1, a 
redox-sensitive kinase that triggers inflammatory MAPK signaling. 
Collectively, these data suggest that grape polyphenols or their metabolites have 
the capacity to protect cells against oxidative damage by (a) neutralizing ROS and RNS 
or transition metals that produce ROS, RNS, and oxiize GSH, (b) decreasing the activity 
of enzymes such as NAPDH oxidase and NOS that produce ROS and RNS, respectively, 
(c) suppressing inflammatory signaling cascades including ASK1 and downstream 
MAPK, and (d) activating transcription factors such as Nrf2 that induce the transcription 
of antioxidant enzymes such as GPx, SOD, HO-1, and GCLC (Figure 2.5). However, 
high levels of these polyphenols may be cytotoxic. 
 
Attenuating Endoplasmic Reticulum Stress Signaling 
The development of obesity and the metabolic syndrome has been linked to ER 
stress and inflammation (reviewed in 49). Endoplasmic reticulum stress activates the 
unfolded protein response (UPR), which involves activ tion of three ER membrane-
associated proteins: (a) double-stranded RNA-activated protein kinase (PKR)-like 
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eukaryotic initiation factor 2α (eIF2α) kinase (PERK), (b) inositol requiring enzyme 1 
(IRE1), and (c) activating transcription factor 6 (ATF6). Studies on flavonols suggest that 
kaempferol (10 µM) or quercetin (25-150 µM) attenuate ER stress in a rat cardiac muscle 
cell line (H9c2 cells) and isolated rat hearts (59) or in human colon cancer cell lines 
(Caco-2 and LS180 cells) (76), respectively, by blocking PERK-mediated eIF2α 
phosphorylation, IRE1-mediated X-box-binding protein 1 activation, and ATF6 
expression (Figure 2.5). In contrast, freeze-dried grape powder (300 µg/ml) did not 
prevent ER stress-mediated apoptosis of human hepatoma cell line (Huh7 cell) and 
primary mouse hepatocytes (126). Research investigating the inhibitory effects of 
anthocyanidins/anthocyanins on ER stress is lacking, a d the preventive effects of grape 
anthocyanidins/anthocyanins and flavonols on ER stres  and chronic inflammation are 
unknown. 
 
Blocking Pro-Inflammatory Cytokines or Endotoxin-Mediated Kinases and 
Transcription Factors Involved in Metabolic Diseases 
Anthocyanins and flavonols modulate inflammation and insulin resistance 
associated with obesity. For example, Zucker fatty ra s fed a high-fat diet supplemented 
with an anthocyanin-rich, 1% tart cherry powder (w/w) for 12 weeks had lower WAT and 
plasma levels of TNFα and interleukin (IL)-6 and WAT NF-κB activity compared with 
controls (101). Dahl salt-sensitive, hypertensive rats supplemented with 3% grape powder 
in the diet (w/w) for 18 weeks had lower plasma leve s of TNFα and IL-6, decreased 
cardiac tissue oxidative damage (102), and reduced expression of inflammatory genes 
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and NF-κB DNA binding activity in cardiac tissue (100) compared with high-sugar 
controls (3% fructose:glucose; 1:1). C57BL/6J mice fed a high-fat diet supplemented for 
eight weeks with an anthocyanin-rich, 4% blueberry powder (w/w) had lower indices of 
inflammation (e.g., decreased gene expression of markers of WAT MΦ and inflammation) 
and oxidative stress and greater insulin sensitivity compared with control mice (33). 
C57BL/6J mice fed a high-fat diet supplemented with 0.8% quercetin in the diet (w/w) 
for eight weeks had lower plasma levels of interferon γ, IL-1α, and IL-4 compared with 
controls (106). Finally, Zucker fatty rats receiving a daily dose of quercetin (2 or 10 
mg/kg body weight, o.p.) for 10 weeks had lower inflammatory markers, improved 
insulin sensitivity and blood lipid profiles, and decreased blood pressure compared with 
placebo controls (94).  
In vitro, cyanidin 3-glucoside (10-40 µM) prevented TNFα-mediated JNK 
activation, IRS-1 phosphorylation at serine residue 307, and insulin resistance in 3T3-L1 
adipocytes (46). Notably, grape seed flavan-3-ols/procyanidins (50 and 100 mg/liter) 
modulated LPS- and TNFα-induced inflammatory signal and gene expression in human 
MΦ (differentiated THP-1 monocytes) and Simpson-Golabi-Behmel Syndrome 
adipocytes, respectively (19). Moreover, oligomerizd grape seed polyphenols (10 and 20 
µg/ml) attenuated activation of inflammatory signalig and production of inflammatory 
cytokines in a murine cell line of adipocytes (HW mouse white adipocytes) co-cultured 
with a murine MΦ cell line (RAW264 cells) (98). Consistent with these data, our lab 
demonstrated that grape powder extract (GPE; 30-100 µg/ml), made from grape powder 
provided by the California Table Grape Commission, attenuated inflammatory gene 
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expression (i.e., IL-6, IL-1β, IL-8, and MCP-1) in primary human adipocytes induced by 
conditioned media collected from LPS-treated MΦ (differentiated U937 monocytes) (81). 
Furthermore, quercetin (3-30 µM), the most abundant polyphenol in GPE (81), prevented 
inflammation in human MΦ and primary human adipocytes treated with MΦ conditioned 
media (82). We showed that pretreatment of human MΦ with quercetin (3-30 µM) 
prevented MΦ-mediated insulin resistance in primary human adipocytes (82). We also 
demonstrated that GPE (10-60 µg/ml) and quercetin (3-60 µM) attenuated TNFα-
mediated inflammation and insulin resistance in prima y human adipocytes by blocking 
activation of ERK, JNK, NF-κB, and AP-1 signaling and negative regulators of insuli  
signaling (e.g., protein tyrosine phosphatase (PTP)-1B and phosphorylation of serine 
residue 307 on IRS) (25, 26). Furthermore, the quercetin content of the cells increased 
within one hour of treatment with 30 µM quercetin, suggesting that quercetin is rapidly 
taken up by human adipocytes (26). No signs of cytotoxicity were observed for these 
doses of GPE or quercetin. 
Quercetin (1-5 µM) suppressed carcinogen-mediated inflammation by directly 
binding to MEK, which prevents activation of inflammatory MEK/MAPK signaling in 
JB6 P+ cells, a JB6 promotion-sensitive mouse skin epidermal cell line (65). Moreover, 
kaempferol (1 and 3µM) inhibited TNFα-mediated inflammation by directly blocking 
nuclear translocation and DNA binding of NF-κB and AP-1 in A549 cells, an alveolar 
epithelial cell carcinoma cell line (21). Taken together, these data suggest that grape 
polyphenols, especially anthocyanins and flavonols, inhibit pro-inflammatory cytokine- 
and metabolic endotoxin-triggered activation of inflammatory MEK/MAPK, NF-κB, and 
18 
 
AP-1 signaling, which increase inflammatory gene expr ssion (e.g., TNFα, IL-6, IL-8, 
IL-1β, and MCP-1) and negative regulators of insulin signaling (Figure 2.6). Therefore, 
grape polyphenols may be useful in preventing inflammatory-mediated insulin resistance 
and other related metabolic diseases. 
 
Suppressing Inflammatory- or Inducing Metabolic-Gene Expression via Increasing 
Histone Deacetylase Activity 
Sirtuins (SIRT), class III histone deacetylases, are nicotinamide adenine 
dinucleotide (NAD+)-dependent deacetylases. Sirtuins deacetylate not only histones, but 
also nonhistone proteins including transcription factors by transferring an acetyl group 
from the targeted protein to NAD+, generating deacetylated histones or nonhistone 
proteins, nicotinamide, and O-acetyl-ADP-ribose. This NAD+ dependency contributes to 
the role that SIRT play in the regulation of chromatin structure and gene expression, cell 
survival, and energy homeostasis. In a SIRT1 in vitro screening assay (51), several 
polyphenols such as trans-resveratrol and quercetin (100 µM) were shown to activate 
SIRT1.  
In vitro (0.01-10 µM) and in vivo (2.5-400 mg/kg body weight/day) studies have 
reported that resveratrol activated SIRT1, thereby (a) decreasing inflammatory gene 
expression by deacetylation/inactivation of NF-κB (39, 79, 128, 132) and (b) improving 
insulin sensitivity by deacetylation/activation of PPARγ coactivator-1 alpha (PGC-1α) 
(62, 111), a regulator of PPAR activity (reviewed in 20). Activation of PPARα or 
PPARβ/δ by PGC-1α also enhances energy expenditure (reviewed in 38, 110). Consistent 
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with these data, quercetin supplementation (12.5 and 25 mg/kg body weight/day) for 
seven days increased SIRT1 and PGC-1α expression and mitochondrial biogenesis in 
male ICR mice (31). These findings suggest that resveratrol and quercetin prevent 
inflammation by activating SIRT1, which deacetylates NF-κB (inactive form) and PGC-
1α (active form), thereby suppressing inflammatory- and inducing metabolic-gene 
expression, mitochondrial biogenesis, and oxidative phosphorylation via activation of 
PPAR (Figure 2.7). However, more research is needed on the regulation of SIRT1 by 
grape polyphenols to determine which specific anthocyanidins and flavonols are involved. 
 
Activating Transcription Factors that Antagonize Chronic Inflammation 
The PPARs (i.e., PPARα, PPARβ/δ, and PPARγ) are ligand-dependent, nuclear 
transcription factors that regulate energy homeostasis, glucose and lipid metabolism, and 
immune response (reviewed in 7). Activation of PPARs has been reported to suppress 
inflammatory gene expression by directly interfering with transcriptional activation of 
NF-κB or AP-1 (reviewed in 93). For example, upon activation by ligand binding, 
PPARγ can be SUMOylated by binding to SUMO1, a small ubiq it n-like modifier. The 
SUMOylated PPARγ subsequently binds to nuclear receptor corepressors, which 
interferes with clearance of the corepressor complex of NF-κB, thereby transrepressing 
LPS-mediated NF-κB activation (83). 
Several studies reported that anthocyanin-rich cherries or berries increase the 
level of PPARγ gene, protein, or activity. For example, the supplementation with 1% tart 
cherry in the diet (w/w) for 12 weeks or 3% grape powder in the diet (w/w) for 18 weeks 
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suppressed inflammation and improved metabolic diseases by increasing PPARγ gene 
expression in Zucker fatty rats (101) or by increasing PPARα/γ mRNA levels and protein 
activity in Dahl salt-sensitive, hypertensive rats (100), respectively. Consistent with these 
data, our lab (26) and others (36) showed that by increasing PPARγ activation, quercetin 
or kaempferol (3-60 µM) attenuated inflammation or insulin resistance in adipocytes. 
These findings suggest that grape polyphenols increase the expression or activation of 
PPARs that antagonize inflammatory transcription factors, thereby blocking 
inflammation and the development of metabolic diseases (Figures 2.6 and 2.7). 
 
Implications and Conclusions 
Potential Health Benefits of Consuming Grapes or Grape Products 
Cardiovascular Disease 
Inflammatory mediators released from excess WAT cause endothelial dysfunction, 
plaque initiation and progression, and plaque rupture, leading to CVD (reviewed in 63). 
Supplementation with quercetin (64 mg/kg body weight/day for 10 and 20 weeks) 
attenuated inflammation and endothelial dysfunction in a mouse model of atherosclerosis 
(ApoE-/- knockout mice) (69). Randomized, clinical trials with proanthocyanidin-rich 
cocoa powder (40 g cocoa powder in 500 ml skim milk/day for four weeks) (73) and 
anthocyanin- and flavonol-rich bilberry juice (330 ml/day for four weeks) (57) showed 
decreased plasma markers of inflammation in adults with high CVD risk who consumed 
these polyphenol-rich products. 
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Consumption of red grape juice (50 ml concentrate twice per day for two weeks) 
reduced serum markers of inflammation and oxidative str ss/oxidized-LDL and improved 
dyslipidemia in hemodialysis patients (16). Consumption of raisins (one cup per day for 
six weeks) reduced systolic blood pressure and inflammatory cytokines and improved 
lipid profiles in men and postmenopausal women (89). Furthermore, consumption of 
grape seed flavan-3-ols procyanidins (0.32 mg/g diet/day for 19 weeks) attenuated 
inflammatory markers in liver, WAT, and circulation i  high-fat-fed, obese male Zucker 
fatty rats (114). Also, consumption of whole table grape powder (3% in the diet, w/w, for 
18 weeks) attenuated systolic blood pressure, cardiac hypertrophy, and diastolic 
dysfunction in Dahl salt-sensitive hypertensive rats (102). Finally, Pérez-Jiménez & 
Saura-Calixto (86) reviewed 75 trials including human and animal studies that 
investigated the relationship between consumption of grapes or grape products and their 
effects on lowering risk factors for CVD including (a) inflammation, (b) oxidative 
stress/LDL oxidation, (c) endothelial dysfunction, (d) platelet aggregation, (e) 
dyslipidemia, and (f) hypertension. They concluded from these studies that grapes and 
grape products have antihypertensive, antihyperlipidemic, antiatherosclerotic, and 
antioxidant effects. Therefore, supplementation with grapes or grape products rich in 
polyphenols may be a useful dietary strategy for the attenuation of CVD associated with 
obesity and inflammation. 
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Insulin Resistance or Diabetes  
Obesity associated, low-grade inflammation causes insulin resistance (Figures 2.1 
and 2.2). Insulin resistance is a prediabetic state characte ized by decreased tissue 
sensitivity to insulin and hyperinsulinemia. These chronic perturbations in glucose 
disposal lead to the development of noninsulin-dependent diabetes (type 2) and 
eventually pancreatic beta cell failure, resulting  insulin-dependent diabetes (type 1) 
(reviewed in 108). Elevated inflammatory TNFα, LPS, SFA, or FFA contribute to 
obesity-associated insulin resistance as shown in Figure 2.2. 
Grape polyphenols such as flavan-3-ols/procyanidins or stilbenes/resveratrol 
improved glucose intolerance in type 1 diabetic rat models (1, 22, 35, 87, 109). 
Resveratrol (0.04% in the diet w/w for 12-48 weeks, or 2.5-400 mg/kg body weight/day 
for 15-16 weeks) improved glucose and lipid homeostasi  in high-fat-fed C57BL/6J 
obese mice (6, 62, 111). Consumption of 150 ml of muscadine grape wine or 
dealcoholized grape wine per day for 28 days improved fasting blood glucose and insulin 
levels in subjects with type 2 diabetes (4). Overall, esults suggest that grapes or grape 
products are good candidates for dietetic management of type 2 diabetes because of their 
abundant polyphenol content and low glycemic index (134). However, clinical studies 
investigating the effect of grape consumption on insulin resistance or type 2 diabetes are 
limited. 
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Cancer 
Obesity-associated inflammation contributes to cancer initiation or progression 
(reviewed in 27, 52, 80). García-Lafuente et al. (42) summarized the potential anti-
inflammatory mechanisms of flavonoids found in fruits and vegetables that are linked to 
the prevention or treatment of cancer. For example, resveratrol prevents certain cancers 
due to its ability to inactivate inflammatory signali g, including protein kinases such as 
MEK/MAPK and transcription factors such as NF-κB and AP-1, and to modulate 
carcinogenic signaling by down-regulation of cyclooxygenase (COX)-2 and iNOS (47, 
54, 72, 113; reviewed in 8, 112, 117).  
Interestingly, the anticarcinogenic effects of red wine extract may be due to not 
only resveratrol but to flavonols as well (65). For example, flavonol/quercetin (9, 24, 64, 
67, 123) and anthocyanidin/delphinidin (53, 61, 120, 131) exert anti-inflammatory and 
anticancer activity. However, most studies used pharmacological doses of these 
polyphenols. Future studies are needed to investigate the relationship between 
physiologically relevant doses of polyphenols from grapes and grape products and their 
ability to prevent or treat certain types of cancer. 
 
Neurodegenerative Diseases linked to Obesity  
Grapes and grape products have been reported to have antiaging and 
antineurodegenerative effects due to their antioxidant properties (reviewed in 55). 
Moreover, rats fed 6.5 ml/kg body weight per day white or red wine or 2.5 mg/kg body 
weight per day resveratrol for two weeks had higher expression levels of genes and 
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proteins related to longevity (74). Consumption of red wine containing 0.2 mg/liter of 
resveratrol for seven months attenuated the development of Alzheimer’s disease (AD) in 
Tg2576 AD transgenic mice due to reduced aggregation of brain amyloid beta-protein 
(119). Grape powder or extract also has been reportd to modulate the pathogenesis of 
neurodegenerative disease (70, 115, 118, 121). However, the extent to which polyphenols 
in grapes other than resveratrol extend lifespan or prevent neurodegenerative diseases is 
unknown, as are their mechanisms of action. 
 
Potential Risks of Excess Consumption of Grapes or Grape Products 
Overconsumption of grapes or grape products could lea to (a) excess weight gain 
due to the high sugar content of grapes, (b) immunosuppression due to the anti-
inflammatory actions of polyphenols, (c) impairment of micronutrient absorption or 
metabolism, and (d) alcohol toxicity associated with excess wine consumption. Of these 
four, the deleterious effects of excess alcohol consumption (e.g., gastrointestinal cancers, 
cirrhosis, pancreatitis, malabsorption, nonsteroidal anti-inflammatory drug interactions, 
impaired judgment, alcoholism, mania) are well-documented risks. Thus, moderation is 
the key with regard to consuming grapes or their by-products, especially alcoholic 
beverages made from grapes. Detrimental effects of consuming high levels of 
supplements made from grapes or their by-products are not well reported in the literature. 
 
 
 
25 
 
Conclusions  
Potential mechanisms by which polyphenol-rich grape products reduce chronic 
inflammation and metabolic diseases associated with obesity are summarized in Figure 
2.8. Chapter III will address the hypothesis that GPE attenuates TNFα-mediated 
inflammation and insulin resistance, possibly by suppressing the activation of ERK, JNK, 
NF-κB, and AP-1, in primary cultures of newly differentiated human adipocytes. Chapter 
IV will address the hypothesis that quercetin and resveratrol, two of important grape 
polyphenols, are absorbed and attenuate TNFα-mediated inflammation and insulin 
resistance, possibly by decreasing ERK, JNK, NF-κB, and AP-1 activity, and increasing 
PPARγ expression and activity, in primary human adipocyte cultures. Chapter V will 
address the hypothesis that several grape powder polyphenols are bioavailable in mice, 
and improve glucose disposal rates and reduce markers of chronic inflammation in high 
fat-fed obese mice.  
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Table 2.1. The content of polyphenols analyzed in freeze-dried table grape powder (GP)a 
 
 
aData are from California Table Grape Commission Information Sheet (2005),  
http://agbioresearch.msu.edu/rfp/ca_grape2009.pdf. 
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Table 2.2. Phenolic phytochemicals found in grapes and grape products 
 
 
aAnthocyanidins/anthocyanins are detected only in red grapes. 
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Figure 2.1. Decreased lipid- and glucose-buffering capacity of adipocytes leads to 
hyperglycemia, hyperlipidemia, and hyperinsulinemia. Nutrient overload in white 
adipose tissue (WAT) leads to insulin resistance [IR; i.e., decreased free fatty acids 
(FFAs) and glucose (GLU) uptake] coupled with increas d secretion of FFAs and pro-
inflammatory adipokines such as tumor necrosis factor alpha (TNFα). Elevated FFAs are 
deposited ectopically in muscle, liver, and pancreas, leading to hyperglycemia, 
hyperlipidemia, and hyperinsulinemia, respectively. TG, triglyceride; PPARγ, 
peroxisome proliferator-activated receptor gamma; VLDL, very low-density lipoprotein 
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Figure 2.2. Mechanisms by which tumor necrosis factor alpha (TNFα), 
lipopolysaccharide (LPS), saturated fatty acids (SFAs), and free fatty acids (FFAs) 
promote inflammation and insulin resistance. Elevated levels of TNFα, LPS, SFA, or 
FFA activate their cognate cell surface receptors or diffuse into the cell, thereby 
activating protein kinases such as protein kinase C (PKC) and mitogen-activated protein 
kinases (MAPKs) or enzymes such as nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase that produce reactive oxygen species (ROS), thereby triggering 
oxidative or endoplasmic reticulum (ER) stress signals or activating inflammatory 
transcription factors such as nuclear factor-kappa B (NF-κB) and activating protein (AP)-
1. Together, these inflammatory signals induce inflammatory gene expression, enhance 
leukocyte recruitment and differentiation including activating monocytes into classically 
activated M1-macrophages (MΦ), antagonize peroxisome proliferator-activated receptor 
gamma (PPARγ) activity, and impair insulin receptor substrate (IRS)-1 signaling, leading 
to insulin resistance. MCP-1, monocyte chemoattractant protein-1; TLR, toll-like receptor; 
TNFR, TNFα receptor 
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Figure 2.3. Mechanisms by which tumor necrosis factor alpha (TNFα) or 
lipopolysaccharide (LPS) antagonizes peroxisome proliferator-activated receptor 
gamma (PPARγ) activity. Tumor necrosis factor α and LPS or their signals antagonize 
PPARγ activity by (a) decreasing PPARγ mRNA levels, (b) phosphorylation (P) of 
PPARγ on serine 112 by extracellular signal-related kinase (ERK), leading to PPARγ 
ubiquination and proteosomal degradation, (c) activating nuclear factor-kappa B (NF-κB), 
which antagonizes PPARγ activity and its DNA binding capacity, or (d) activating 
nuclear corepressors, which decrease PPARγ transcriptional activity and target gene 
expression. Collectively, this leads to insulin resistance in white adipose tissue, thereby 
elevating circulating free fatty acids (lipodystrophy) and glucose (hyperglycemia) that 
promote ectopic lipid deposition in liver, skeletal muscle, heart, and pancreas. 9-cis RA, 
9-cis retinoic acid; aP2, adipocyte fatty acid-binding protein; GLUT4, insulin-dependent 
glucose transporter 4; LPL, lipoprotein lipase; PPRE, peroxisome proliferator response 
element; RXR, retinoid X receptor, TG, triglyceride 
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Figure 2.4. Structures of polyphenols commonly found in grape products.
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Figure 2.5. Potential mechanisms by which grape polyphenols prev nt chronic 
inflammation associated with obesity. Grape polyphenols may attenuate oxidative or 
endoplasmic reticulum (ER) stress-mediated inflammation associated with obesity by (a) 
inhibiting the activity of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 
or nitric oxide synthase (NOS) that generate reactive oxygen species (ROS) or reactive 
nitrogen species (RNS), respectively, (b) acting as a classic antioxidant by directly 
scavenging ROS and RNS, (c) preventing ROS-mediated activation of apoptosis signal-
regulated kinase 1 (ASK1), a redox-sensitive, inflammatory signaling pathway, (d) 
increasing the expression of antioxidant genes such as glutathione peroxidase (GPx), 
superoxide dismutase (SOD), heme oxygenase (HO)-1, and γ-glutamate-cysteine ligase 
catalytic subunit (GCLC) via activation of transcription factor nuclear factor-erythroid 2 
(NF-E2)-related factor 2 (Nrf2), or (e) blocking ER stress-mediated unfolded protein 
response including double-stranded RNA-activated protein kinase (PKR)-like eukaryotic 
initiation factor 2α (eIF2α) kinase (PERK)-mediated eIF2α, inositol requiring enzyme 1 
(IRE1)-mediated X-box binding protein 1 (XBP1), and activating transcription factor 6 
(ATF6) signaling pathways that trigger proinflammatory gene expression. AP-1, 
activating protein-1; GSH, reduced glutathione; GSS, oxidized glutathione; JNK, c-Jun-
NH2 terminal kinase; NF-κB, nuclear factor-kappa B; P, phosphorylated; Trx1, 
thioredoxin-1 
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Figure 2.6. Grape polyphenols may prevent inflammation and insulin resistance 
associated with obesity by blocking activation of mitogen-activated protein kinases 
(MAPKs), nuclear factor-kappa B (NF-κB), and activating protein (AP)-1. Grape 
polyphenols may prevent inflammatory tumor necrosis factor alpha (TNFα)/TNF receptor 
(TNFR) or lipopolysaccharide (LPS)/toll-like receptor (TLR) signaling to MAPK kinases 
(MEK) and their downstream, extracellular signal-relat d kinase (ERK) and c-Jun-NH2 
terminal kinase (JNK). This would attenuate the activ tion of inflammatory transcription 
factors NF-κB and AP-1, which are potent inducers of inflammatory gene expression 
[e.g., TNFα, interleukin (IL)-6, IL-8, IL-1β, and monocyte chemoattractant protein 
(MCP)-1] and negative regulators of insulin signalig [e.g., phosphorylation of serine 
residue 307 on insulin receptor substrate (IRS) and protein tyrosine phosphatase (PTP)-
1B], and which suppress insulin signaling necessary fo  insulin-dependent glucose 
transporter 4 (GLUT4) translocation to the plasma membrane. AKT, AKT/protein kinase 
B; GLU, glucose; IKK, IκBα kinase; PI3 K, phosphatidylinositol 3-kinases; P, 
phosphorylated; PPAR, peroxisome proliferator-activated receptor; Ser, serine; Tyr, 
tyrosine; Ub, ubiquinated degradation 
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Figure 2.7. Grape polyphenols may activate sirtuin 1 (SIRT1) and peroxisome 
proliferator-activated receptor (PPAR) that antagonize inflammation and improve 
the metabolic diseases associated with obesity. Grape polyphenols may prevent 
inflammation and improve metabolic diseases associated with obesity by activating 
SIRT1. SIRT1 has been reported to (a) deacetylate/inactivate nuclear factor-kappa B 
(NF-κB), resulting in the suppression of inflammatory gene expression, and (b) 
deacetylate/activate PPARγ coactivator-1 alpha (PGC-1α), resulting in the activation of 
PPARs. Activation of PPARα and PPARβ/δ increases oxidative phosphorylation, 
metabolic gene expression, and mitochondrial (Mito) bi genesis. Activation of PPARγ 
may antagonize NF-κB transcriptional activation of inflammatory genes, thereby 
attenuating inflammation associated with obesity. 
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Figure 2.8. Summary of potential mechanisms by which polyphenol-rich grape 
products reduce chronic inflammation and metabolic diseases associated with 
obesity. AP-1, activating protein-1; ER, endoplasmic reticulum; MAPK, mitogen-
activated protein kinase; NF-κB, nuclear factor-kappa B; PPAR, peroxisome proliferator-
activated receptor; PGC-1, PPARγ coactivator-1; ROS, reactive oxygen species; SIRT, 
sirtuins 
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CHAPTER III 
 
 GRAPE POWDER EXTRACT ATTENUATES TUMOR NECROSIS FACTOR α-
MEDIATED INFLAMMATION AND INSULIN RESISTANCE IN PRIMARY 
CULTURES OF HUMAN ADIPOCYTES 
 
 
Abstract 
Grapes are rich in phenolic phytochemicals that posses  anti-oxidant and anti-
inflammatory properties. However, the ability of grape powder extract (GPE) to prevent 
inflammation and insulin resistance in human adipocytes caused by tumor necrosis factor 
α (TNFα), a cytokine elevated in plasma and white adipose tissue (WAT) of obese, 
diabetic individuals, is unknown. Therefore, we examined the effects of GPE on markers 
of inflammation and insulin resistance in primary cultures of newly differentiated human 
adipocytes treated with TNFα. We found that GPE attenuated TNFα-induced expression 
of inflammatory genes including interleukin (IL)-6, IL-1β, IL-8, monocyte 
chemoattractant protein (MCP)-1, cyclooxygenase (COX)-2 and Toll-like receptor 
(TLR)-2. GPE attenuated TNFα-mediated activation of extracellular signal-related kinase 
(ERK) and c-Jun NH2-terminal kinase (JNK) and activator protein-1 (AP-1, i.e., c-Jun). 
GPE also attenuated TNFα-mediated IκBα degradation and nuclear factor-kappa B (NF-
κB) activity. Finally, GPE prevented TNFα-induced expression of protein tyrosine 
phosphatase (PTP)-1B and phosphorylation of serine residue 307 of insulin receptor 
substrate-1 (IRS-1), which are negative regulators of insulin sensitivity, and suppression 
of insulin-stimulated glucose uptake. Taken together, these data demonstrate that GPE 
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attenuates TNFα-mediated inflammation and insulin resistance in human adipocytes, 
possibly by suppressing the activation of ERK, JNK, c-Jun and NF-κB. 
 
Introduction 
Obesity is associated with low-grade, chronic inflammation of white adipose 
tissue (WAT) characterized by increased production of pro-inflammatory cytokines such 
as tumor necrosis factor α (TNFα) [1]. The inflammatory effects of TNFα involve the 
activation of nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1) [2-4]. 
Several studies have shown that activation of these transcription factors was responsible 
for increasing the expression of inflammatory cytokines such as interleukin (IL)-6, IL-1β, 
IL-8, and monocyte chemoattractant protein (MCP)-1 [3,5] and inflammatory proteins 
such as Toll-like receptor (TLR)-2 [6] and cyclooxygenase (COX)-2, which contributes 
to inflammatory prostaglandin production [7].  
Obesity-associated inflammation plays an important role in the development of 
insulin resistance. Several studies reported that deletions of inflammatory cytokine genes 
including TNFα, IL-6 or MCP-1 protect against the development of insulin resistance and 
hyperglycemia in obese mice [8-11]. Moreover, inhibition of COX-2 activation in rats 
[12] and disruption of TLR expression in mice [13] protect against obesity-induced 
inflammation and insulin resistance. Furthermore, TNFα-activated mitogen-activated 
protein kinase (MAPK) signaling pathways, including extracellular signal-related kinase 
(ERK) and c-Jun-NH2 terminal kinase (JNK), contribute to the development of insulin 
resistance [14-17]. Insulin receptor substrate 1 (IRS-1) is one of the targets for ERK and 
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JNK that phosphorylate serine residues of IRS-1, which impairs the ability of the insulin 
receptor to phosphorylate tyrosine residues of IRS-1 [18], thereby reducing insulin action 
[17]. Finally, TNFα activates NF-κB, which in turn enhances the gene expression of 
protein tyrosine phosphatase (PTP)-1B, a negative regulator of insulin signaling, by 
dephosphorylating tyrosine residues on IRS-1 [19-21]. 
Grapes are rich in phenolic phytochemicals and are on of the most widely 
consumed fruits in the world. Human [22] and animal [23-25] studies have shown that 
lyophilized grape powder has cardioprotective effects due to its abundant content of 
polyphenols that possess anti-oxidative and anti-inflammatory properties. Furthermore, 
several polyphenols in grapes such as resveratrol [26] and quercetin [27,28] reduce 
inflammation or insulin resistance in rodent models. However, the protective effects of 
grapes or their byproducts on inflammation and insul  resistance in WAT are unclear, 
and the mechanisms by which grape products protect against inflammation and insulin 
resistance in human adipocytes are unknown.  
Therefore, we investigated the extent to which grape powder extract (GPE) 
attenuated TNFα-mediated inflammation and insulin resistance in prima y cultures of 
human adipocytes. We hypothesized that GPE attenuatd TNFα-mediated induction of 
inflammatory genes and insulin resistance by suppressing the activation of MAPK, AP-1, 
or NF-κB. 
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Materials and Methods 
Preparation of GPE 
Lyophilized grape powder, obtained from red, green and blue-purple seeded and 
seedless California grapes, was acquired from the California Table Grape Commission 
(CTGC). The CTGC grape powder has been reported to contain several types of 
polyphenols including anthocyanins, monomeric flavanols, flavonols and stilbenes [25]. 
The powder was extracted to remove the sugars (90% w/w) at the University of North 
Carolina at Greensboro (UNCG) using a Diaion HP-20 anion resin column and eluted 
from the column using methanol and subsequently lyophilized to become GPE. GPE was 
dissolved in dimethyl sulfoxide (DMSO) to make the concentration of 100 mg/ml as the 
stock solutions stored at -20°C. Stock solutions were diluted immediately before use. 
 
Materials 
All cell culture ware were purchased from Fisher Scientific (Norcross, GA, USA). 
Adipocyte medium was purchased from Zen Bio, Inc. (Research Triangle Park, NC, 
USA). Tri-Reagent was purchased from Molecular Research Center (Cincinnati, OH, 
USA). Gene-specific primers were purchased from Applied Biosystems (Foster City, CA, 
USA). Goat polyclonal antibody for anti-glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-
phospho (Thr183/Tyr185) and -total JNK, anti-phospho (Thr202/Tyr204) and -total ERK, 
anti-phospho (Ser63) and -total c-Jun, anti-phospho (Ser307) and -total IRS-1, and anti- 
IκBα rabbit polyclonal antibodies were purchased from Cell Signaling Technologies 
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(Beverly, MA, USA). Immunoblotting buffers and precast gels were purchased from 
Invitrogen (Carlsbad, CA, USA). Western Lightning Plus Chemiluminescence Substrate 
was purchased from Perkin Elmer Life Science (Boston, MA, USA). The Nucleofector 
and Dual Glo luciferase kits were obtained from Amaxa (Cologne, Germany) and 
Promega (Madison, WI, USA), respectively. All other reagents and chemicals were 
purchased from Sigma (St. Louis, MO, USA) unless otherwise stated. 
 
Primary cultures of human adipocytes 
Abdominal WAT was obtained from nondiabetic, Caucasian and African-
American females, between the ages of 20 and 50 years old with a body mass index less 
than 32.0 during abdominoplasty. Approval was obtained from the Institutional Review 
Board at UNCG and the Moses Cone Memorial Hospital in Greensboro, NC, USA. 
Tissue was digested using collagenase, and stromal vascular (SV) cells were isolated, 
proliferated and induced to differentiate in adipocyte medium (AM-1, Zen Bio, Inc., RTP, 
NC, USA) plus 250 µmol/L isobutylmethylxanthine and 1 µmol/L of the 
thiazolidinedione rosiglitazone (BRL 49653, a gift from Dr. Per Sauerberg at Nova 
Nordisk A/S, Copenhagen, Denmark) for 3 days. Cultures were then grown in AM-1 only 
for 3-9 days as previously described [29]. Cultures containing ∼50% preadipocytes and 
∼50% adipocytes, based on visual observations, were tr ated between Days 6 and 12 of 
differentiation. Each experiment was repeated at lest twice at different times using a 
mixture of cells from two to three subjects unless otherwise indicated. 
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RNA isolation and real-time qPCR 
Primary human SV cells were seeded in 35-mm dishes at 0.4×106 per dish and 
differentiated for 6 days. On Day 6, media was changed. Twenty-four hours later, 
cultures were pretreated with DMSO vehicle (0) or with 10, 30 or 60 µg/ml GPE for 1 h 
and subsequently treated with 0.5 ng/ml TNFα for 3 h. This 3-h treatment with TNFα was 
chosen based on the results of a pilot dose and time-course study (data not shown). 
Following treatment, cultures were harvested and total RNA was isolated using TRI-
Reagent according to the manufacturer's protocol. For real-time qPCR, 2.0 µg total RNA 
was converted into first-strand cDNA using Applied Biosystems High-Capacity cDNA 
Archive Kit. Real-time qPCR was performed in an Applied Biosystems 7500 FAST Real 
Time PCR System using Taqman Gene Expression Assays. To account for possible 
variation related to cDNA input or the presence of PCR inhibitors, the endogenous 
reference gene GAPDH was simultaneously quantified for each sample, and data were 
normalized accordingly. 
 
Immunoblotting 
Primary human SV cells were seeded in 35-mm dishes at 0.4×106 per dish and 
differentiated for 6 days. On Day 6, media was changed. Twenty-four hours later, 
cultures were pretreated with DMSO vehicle (0) or with 10, 30 or 60 µg/ml GPE for 1 h 
and then treated with 0.5 ng/ml TNFα for 15 min. This 15-min treatment with TNFα was 
chosen based on the results of a pilot dose and time-course study (data not shown). 
Immunoblotting was conducted as previously described [30]. 
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Transient transfections of human adipocytes 
For measuring NF-κB activity, primary cultures of human adipocytes were 
transiently transfected with the NF-κB responsive luciferase (luc) reporter construct pNF-
κB (Strategene, La Jolla, CA, USA) using the Amaxa Nucleofector system from Lonza 
Inc. (Walkersville, MD, USA). Briefly, on Day 6 of differentiation, 1.2×106 cells from a 
60-mm plate were trypsinized and resuspended in 100 µl of Amaxa Nucleofector solution 
(cell line nucleofector kit V) and mixed with 1 µg of pNF-κB and 25 ng pRL-CMV for 
each sample. Electroporation was performed using the Amaxa Nucleofector Device (V-
33 Nucleofector program). Cells were replated in 96-well plates after 10 min of recovery 
in calcium-free DMEM media. Following 24 h, transfect d cells were pretreated with 
DMSO vehicle (0) or with 10, 30 or 60 µg/ml GPE for 1 h and then treated with 100 
ng/ml TNFα for 24 h. This 24-h treatment with TNFα was chosen based on the results of 
a pilot dose and time-course study (data not shown). Firefly luciferase activity was 
measured using the Promega Dual-Glo luciferase kit and normalized to renilla luciferase 
activity from the co-transfected control pRL-CMV vector. All luciferase data will be 
presented in relative light units as the ratio of firefly luciferase to renilla luciferase 
activity. 
 
2-[3H]Deoxy-glucose uptake 
Primary human SV cells were seeded in 12-well plates t 1.6×105 per well and 
differentiated for 12 days. On Day 12, media was changed to serum-free low glucose (5 
mmol/L) and insulin (20 pmol/L)-containing media. Twenty-four hours later, cultures 
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were pretreated with DMSO vehicle (0) or with 10, 3 or 60 µg/ml GPE for 1 h and then 
treated with 5 ng/ml TNFα for 24 h. This 24-h treatment with TNFα was chosen based on 
the results of a pilot dose and time-course study (data not shown). Culture media was 
removed and replaced with 0.5 ml of HBSS buffer containing 100 nmol/L human insulin 
for 10 min. After insulin preincubation, 2-[3H]deoxy-glucose (2-DOG) was added to a 
final concentration of 0.5 µCi per well and incubated at 37°C for 90 min. Basal and 
insulin-stimulated 2-DOG uptake were measured as described previously [30]. 
 
Statistical analysis 
Statistical analyses were performed for data in Figures 3.1, 3.3B and 3.4A by 
testing the main effects of TNFα (− or +), GPE alone (0, 10, 30 or 60 µg/ml) and their 
interaction (TNFα×GPE) using two-way ANOVA (SPSS version 16.0 for Windows, SAS 
Institute, Cary, NC, USA). Statistical analyses were performed for data in Figure 3.4C 
by using one way ANOVA (SPSS version 16.0 for Windows). Tukey's HSD tests were 
used to compute individual pairwise comparisons of means (P<.05). Data are expressed 
as means±S.E.M. 
 
Results 
GPE blocks TNFα-induced inflammatory gene expression 
To investigate the protective effects of GPE on TNFα-induced inflammation in 
human adipocytes, we pretreated primary cultures of newly differentiated human 
adipocytes with varying doses of GPE for 1 h followed by 3 h of TNFα treatment to 
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induce inflammatory gene expression. GPE decreased TNFα-induced expression of IL-6, 
IL-1β, IL-8, MCP-1, COX-2 and TLR-2 in a dose-dependent manner (Figure 3.1). No 
visible signs of GPE cytotoxicity were noted (e.g., no floating cells, no abnormal changes 
in cell morphology of the monolayer). These data demonstrate that GPE blocks TNFα-
induced inflammatory gene expression in primary cultures of newly differentiated human 
adipocytes. 
 
GPE prevents TNFα-mediated ERK and JNK activation 
Because the phosphorylation of MAPK plays an important role in activating 
transcription factors that induce inflammatory gene expression, we investigated the 
impact of GPE on MAPK phosphorylation. We found that 1-h pretreatment of cultures of 
human adipocytes with GPE blocked basal and TNFα-mediated phosphorylation of ERK 
and JNK in a dose-dependent manner (Figure 3.2). These data demonstrate that GPE 
prevents TNFα activation of ERK and JNK in primary cultures of newly differentiated 
human adipocytes. 
 
GPE decreases TNFα-mediated c-Jun and NF-κB activation 
Given the important role that AP-1 and NF-κB play in the transcriptional 
activation of inflammatory genes, we examined the preventive effects of GPE on AP-1 
and NF-κB activation. Pretreatment of the cultures with GPE for 1 h decreased TNFα-
mediated phosphorylation of c-Jun, a component of AP-1 and a downstream target of 
JNK (Figure 3.3A). Similarly, GPE blocked basal and TNFα-induced IκBα degradation 
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(Figure 3.3A). Consistent with these data, GPE attenuated TNFα-stimulated NF-κB 
reporter activity in a dose-dependent manner (Figure 3.3B). Taken together, these data 
demonstrate that GPE decreases TNFα-mediated c-Jun phosphorylation and NF-κB 
activity in primary cultures of newly differentiated human adipocytes. 
 
GPE prevents TNFα-mediated insulin resistance 
Increased activation of MAPK, AP-1 and NF-κB, and inflammatory gene 
expression cause insulin resistance. This causal relationship has been linked to increased 
TNFα levels in plasma and WAT of obese individuals [1].Thus, we examined the ability 
of GPE to prevent TNFα-mediated insulin resistance in adipocytes, using increased PTP-
1B expression and phosphorylation serine residue 307 of IRS-1 (p-Ser307-IRS-1), which 
are negative regulators of insulin sensitivity, and decreased insulin-stimulated 2-DOG 
uptake as indicators of insulin resistance. GPE decreased TNFα-mediated PTP-1B 
expression (Figure 3.4A) and p-Ser307-IRS-1 (Figure 3.4B), and increased insulin-
stimulated 2-DOG uptake (Figure 3.4C) in a dose-dependent manner. Collectively, these 
data demonstrate that GPE prevents TNFα-mediated insulin resistance in primary 
cultures of newly differentiated human adipocytes, possibly by inhibiting upstream 
mediators of inflammation and their downstream negative regulators of insulin sensitivity. 
 
Discussion 
In this study, we demonstrated the protective effects of GPE on TNFα activation 
of upstream proteins and induction of inflammatory genes and negative regulators of 
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insulin sensitivity in primary cultures of newly differentiated human adipocytes. We 
demonstrated that (1) GPE attenuated TNFα-induced expression of IL-6, IL-1β, IL-8, 
MCP-1, COX-2 and TLR-2 (Figure 3.1); (2) GPE attenuated TNFα activation of ERK 
and JNK (Figure 3.2), MAPK linked to the activation of NF-κB and c-Jun, a component 
of AP-1; (3) GPE prevented TNFα activation of c-Jun and attenuated TNFα-mediated 
IκBα degradation and NF-κB activity (Figure 3.3); and (4) GPE prevented TNFα-
induced expression of PTP-1B and phosphorylation of serine residue 307 of IRS-1, which 
are negative regulators of insulin sensitivity, and suppression of insulin-stimulated 
glucose uptake (Figure 3.4). Taken together, these findings are the first to demonstrate 
that GPE inhibits TNFα-mediated activation of ERK and JNK and transcription factors 
AP-1 and NF-κB that induce inflammatory genes known to cause insuli  resistance in 
human adipocytes. 
Based on these data, we propose the following scenario by which GPE reduces 
TNFα-mediated inflammation and insulin resistance (Figure 3.5). We speculate that GPE 
initially attenuates TNFα-mediated activation of MAPK, AP-1 and NF-κB at 15 min. 
This GPE-mediated decrease in MAPK, AP-1 and NF-κB activation, in turn, attenuates 
TNFα-induced expression of inflammatory genes (i.e., IL-6, IL-1β, IL-8, MCP-1, COX-2 
and TLR-2) at 3 h. This results in decreased autocrine/paracrine activation of the 
inflammatory cascade, including attenuation of negative regulators of insulin sensitivity 
(i.e., PTP-1B and p-Ser307-IRS-1). 
TNFα was identified as one of the first links between obesity-associated 
inflammation and insulin resistance [8]. Elevated production of TNFα by WAT was 
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reported in obese humans and is positively correlated with impaired glucose disposal [1]. 
However, mechanism(s) by which TNFα signals to its downstream targets in human 
adipocytes is (are) unclear. The activation of MAPK, AP-1 and NF-κB signaling by 
TNFα has been reported to cause inflammation and insulin resistance in several cell lines 
[2,16,18]. Consistent with these studies, we found that TNFα activates ERK, JNK, c-Jun 
and NF-κB, which together increase inflammatory gene expression and induce insulin 
resistance in primary cultures of newly differentiated human adipocytes. 
Several studies have examined the anti-inflammatory p operties of grape 
byproducts rich in phytochemicals such as wine, grape juice and grape seeds [31]. For 
example, Sakurai et al. [32] demonstrated that oligomerized grape seed polyphenols 
attenuated inflammation in cocultures of adipocytes and macrophages via their anti-
oxidative properties. Lee et al. [33] demonstrated that red wine extract (RWE) inhibited 
12-O-tetradecanoylphorbol-13-acetate (TPA)-induced transformation of JB6 promotion-
sensitive mouse skin epidermal (JB6 P+) cells by blocking the activation of 
Raf/MEK/ERK/p90RSK signaling pathway and subsequently suppressing the activation 
of AP- 1 and NF-κB transcription factors. Similarly, our data showed that GPE attenuated 
TNFα-mediated inflammation and insulin resistance, in part, by suppressing the 
activation of ERK, JNK, c-Jun and NF-κB.  
We also demonstrate that GPE effectively prevents TNFα-mediated insulin 
resistance in human adipocytes. Notably, GPE attenuat d TNFα-induced expression of 
PTP-1B and phosphorylation of serine residue 307 of IRS-1, which are negative 
regulators of insulin sensitivity. Phosphorylation f serine residues of IRS-1 is one of the 
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most common mechanisms by which MAPK and IκB kinase-β, a central coordinator of 
inflammatory responses through activation of NF-κB, decrease insulin-stimulated glucose 
uptake [34]. The activation of MAPK by TNFα increased the phosphorylation of serine 
residues on IRS-1 [18], which impairs the ability of the insulin receptor to phosphorylate 
tyrosine residues of IRS-1, thereby reducing insulin action [17]. PTP-1B, an NF-κB 
target gene [19,20], negatively regulates insulin se sitivity by dephosphorylating tyrosine 
residues of IRS-1 [21]. Thus, TNFα-induced PTP-1B gene expression [35] contributes to 
insulin resistance. Here, we demonstrate that GPE prevents TNFα-mediated insulin 
resistance in primary cultures of newly differentiated human adipocytes, possibly by 
inhibiting the activation of upstream mediators of inflammation such as ERK, JNK, c-Jun 
or NF-κB and their downstream negative regulators of insul sensitivity such as PTP-1B 
expression and phosphorylation of serine residue 307 of IRS-1. 
Lee et al. [33] found that the anticarcinogenic effects of RWE may be due to the 
higher content of the flavonol quercetin, as compared to the phytoalexin resveratrol. It 
has been reported that quercetin has anti-inflammatory properties. For example, quercetin 
supplementation of high fat-fed mice [27] or obese Zucker rats [28] reduced circulating 
markers of inflammation. In vitro, quercetin attenuated differentiation and markers of 
inflammation in murine 3T3-L1 adipocytes [36] and suppressed TPA-mediated activation 
of MEK/ERK, AP-1 and NF-κB in murine skin epidermal (JB6 P+) cells [33]. Notably, 
we found using reverse-phase HPLC that one of the major components in GPE was 
quercetin glucosides (9.2%) (unpublished data). However, quercetin glucosides may not 
exist in circulation, because β-glucosidase hydrolysis of quercetin glucosides occurs 
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when GPE polyphenols are absorbed across the intestine and pass through the liver 
[37,38]. Also, the concentrations of quercetin found i  circulation vary markedly, ranging 
from 0.1 to 10 µM [39,40]. Therefore, the doses of 10, 30 and 60 µg/ml GPE will contain 
∼3, 9 and 18 µM quercetin (molecular weight, 302.2), respectively. Thus, the 10 and 30 
µg/ml GPE may provide physiological levels of quercetin for those consuming a diet rich 
in grape products. 
The other components we found in GPE were catechins (4.2%), gallic acid (1.4%) 
and resveratrol (0.53%) (unpublished data). Resveratrol is a potential anti-inflammatory 
polyphenol in GPE. Several animal studies reported that resveratrol prevents insulin 
resistance and adiposity in mice fed a high-fat die[26,41,42]. These studies suggest that 
resveratrol shifts excess calories away from storage in WAT and towards oxidation in 
muscle and brown adipose tissue. In vitro, resveratrol has been shown to reduce 
inflammation in murine 3T3-L1 adipocytes [43], enhace glucose transport in muscle 
[44], reduce oxidative stress in human lung epithelial cells [45,46], reduce ER stress in 
mouse macrophages [47] and decrease TNFα-mediated NF-κB activation in hepatocytes 
[48] and coronary arterial endothelial cells [49]. Studies are underway in our laboratory 
to determine the extent to which quercetin, resveratrol nd other polyphenol candidates in 
GPE prevent inflammation and insulin resistance in primary cultures of human 
adipocytes. 
Collectively, these data demonstrate that GPE attenuat s TNFα-mediated 
inflammation and insulin resistance by suppressing the activation of ERK, JNK, c-Jun, 
and NF-κB that induce the expression of inflammatory genes and negative regulators of 
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insulin sensitivity in primary cultures of newly differentiated human adipocytes. In vivo 
studies are needed to determine the ability of GPE to recapitulate these in vitro findings 
in WAT, because of the extensive metabolism of polyhenols in vivo [50]. 
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Figure 3.1. GPE blocks TNFα-induced inflammatory gene expression. Cultures of 
newly differentiated human adipocytes were pretreated with DMSO vehicle (0) or with 
10, 30 or 60 µg/ml GPE for 1 h and then treated with 0.5 ng/ml TNFα for 3 h. 
Subsequently, cultures were harvested for the determination of mRNA levels of IL-6, IL-
1β, IL-8, MCP-1, COX-2 and TLR-2 by real-time qPCR. Data are representative of three 
independent experiments. Values are means±S.E.M., n=3. Means without a common 
letter differ, P<.05. 
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Figure 3.2. GPE prevents TNFα activation of ERK and JNK. Cultures of newly 
differentiated human adipocytes were pretreated with DMSO vehicle (0) or with 10, 30 or 
60 µg/ml GPE for 1 h and then treated with 0.5 ng/ml TNFα for 15 min. Subsequently, 
cultures were harvested for the determination of the protein levels of p-ERK, ERK, p-
JNK and JNK by immunoblotting. Data are representative of three independent 
experiments. 
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Figure 3.3. GPE decreases TNFα-mediated c-Jun activation, IκBα degradation and 
NF-κB transcriptional activity.  (A) Cultures of newly differentiated human adipocytes 
were pretreated with DMSO vehicle (0) or with 10, 3 or 60 µg/ml GPE for 1 h and then 
treated with 0.5 ng/ml TNFα for 15 min. Subsequently, cultures were harvested for the 
determination of the protein levels of p-c-Jun, c-Jun, IκBα and GAPDH by 
immunoblotting. (B) Cultures were transfected on Day 6 with pNF-κB luc and pRL-
CMV. Twenty four hours later, transfected cells were p etreated with DMSO vehicle (0) 
or with 10, 30 or 60 µg/ml GPE for 1 h and then treated with 100 ng/ml TNFα for 24 h. 
(A) Data are representative of three independent experiments. (B) Values are 
means±S.E.M., n=6. Means without a common letter differ, P<.05. 
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Figure 3.4. GPE prevents TNFα-mediated insulin resistance. (A) Cultures of newly 
differentiated human adipocytes were pretreated with DMSO vehicle (0) or with 10, 30 or 
60 µg/ml GPE for 1 h and then treated with 0.5 ng/ml TNFα for 3 h to determine the 
mRNA level of PTP-1B by real-time qPCR, or (B) for 15 min to determine the protein 
level of p-Ser307-IRS-1 by immunoblotting. (C) Cultures were incubated with serum free 
low glucose media for 24 h and then pretreated withDMSO vehicle (0) or with 10, 30 or 
60 µg/ml GPE for 1 h and then treated with 5 ng/ml TNFα for 24 h. Insulin-stimulated 2-
DOG uptake was measured after a 100-min incubation with 100 nmol/L insulin. (A,B) 
Data are representative of two independent experiments. (A) Values are means±S.E.M., 
n=3. (C) Data are representative of two independent experiments. Values are 
means±S.E.M., n=4. Means without a common letter differ, P<.05. 
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Figure 3.5. Working model on how GPE prevents TNFα-mediated inflammation 
and insulin resistance. We propose that GPE initially blocks the activation of MAPK, 
AP-1 and NF-κB. This prevents them from inducing inflammatory gene expression, 
thereby blocking autocrine/paracrine signals associated with propagating the 
inflammatory cascade. By preventing this inflammatory cascade, GPE decreases TNFα-
mediated IRS-1-serine phosphorylation and increases IRS-1-tyrosine phosphorylation. 
Increased IRS-1 tyrosine phosphorylation increases GLUT4 translocation to the plasma 
membrane, thereby facilitating glucose uptake. 
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CHAPTER IV 
 
QUERCETIN IS EQUALLY OR MORE EFFECTIVE THAN RESVERATROL IN 
ATTENUATING TUMOR NECROSIS FACTOR-α–MEDIATED INFLAMMATION 
AND INSULIN RESISTANCE IN PRIMARY HUMAN ADIPOCYTES 
 
 
Abstract 
Background: Quercetin and trans-resveratrol (trans-RSV) are plant polyphenols 
reported to reduce inflammation or insulin resistance associated with obesity. Recently, 
we showed that grape powder extract, which contains quercetin and trans-RSV, 
attenuates markers of inflammation in human adipocytes and macrophages and insulin 
resistance in human adipocytes. However, we do not k w how quercetin and trans-RSV 
individually affected these outcomes. 
Objective: The aim of this study was to examine the extent to which quercetin and trans-
RSV prevented inflammation or insulin resistance in primary cultures of human 
adipocytes treated with tumor necrosis factor-α (TNF-α), an inflammatory cytokine 
elevated in the plasma and adipose tissue of obese, diabetic individuals. 
Design: Cultures of human adipocytes were pretreated with quercetin and trans-RSV 
followed by treatment with TNF-α. Subsequently, gene and protein markers of 
inflammation and insulin resistance were measured. 
Results: Quercetin, and to a lesser extent trans-RSV, attenuated the TNF-α–induced 
expression of inflammatory genes such as interleukin (IL)-6, IL-1β, IL-8, and monocyte 
chemoattractant protein-1 (MCP-1) and the secretion of IL-6, IL-8, and MCP-1.
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Quercetin attenuated TNF-α–mediated phosphorylation of extracellular signal-related 
kinase and c-Jun-NH2 terminal kinase, whereas tr ns-RSV attenuated only c-Jun-NH2 
terminal kinase phosphorylation. Quercetin and trans-RSV attenuated TNF-α–mediated 
phosphorylation of c-Jun and degradation of inhibitory κB protein. Quercetin, but not 
trans-RSV, decreased TNF-α–induced nuclear factor-κB transcriptional activity. 
Quercetin and trans-RSV attenuated the TNF-α–mediated suppression of peroxisome 
proliferator-activated receptor γ (PPARγ) and PPARγ target genes and of PPARγ protein 
concentrations and transcriptional activity. Quercetin prevented the TNF-α–mediated 
serine phosphorylation of insulin receptor substrate-1 and protein tyrosine phosphatase-
1B gene expression and the suppression of insulin-stimulated glucose uptake, whereas 
trans-RSV prevented only the TNF-α–mediated serine phosphorylation of insulin 
receptor substrate-1. 
Conclusion: These data suggest that quercetin is equally or more effective than trans-
RSV in attenuating TNF-α–mediated inflammation and insulin resistance in prima y 
human adipocytes. 
 
Introduction 
Obesity or excess white adipose tissue (WAT) is associated with increased 
production of proinflammatory cytokines such as interleukin (IL)-6 and tumor necrosis 
factor-α (TNF-α), which contribute to chronic, low-grade inflammation (1, 2). 
Hotamisligil et al (3) first reported that the overexpression of TNF-α was intimately 
involved in the development of inflammation-associated insulin resistance in the WAT of 
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obese mice. To date, numerous articles support this seminal finding and extend our 
understanding of how obesity increases TNF-α production in WAT, which causes local 
and systemic inflammation and insulin resistance (4-6). 
TNF-α causes inflammation by triggering a serine/threonine kinase 
phosphorylation cascade that activates mitogen-activated protein kinases (MAPK) such 
as extracellular signal-related kinase (ERK) and c-Jun NH2 terminal kinase (JNK) and 
transcription factors such as nuclear factor-κB (NF-κB) and activator protein (AP)-1 (7, 
8). Together, these proteins indirectly cause insul resistance by inducing the 
transcription of inflammatory genes and antagonizing peroxisome proliferator-activated 
receptor γ (PPARγ) activity (6) or directly impair insulin signaling via decreasing insulin 
receptor substrate (IRS)-1/2 signaling (9). In addition, TNF-α–mediated activation of NF-
κB enhances the expression of protein tyrosine phosphatase (PTP)-1B, a negative 
regulator of insulin signaling that dephosphorylates tyrosine residues on IRS-1 (10-12). 
Thus, TNF-α can cause insulin resistance by increasing the serine phosphorylation of 
IRS-1/2 via JNK and decreasing the tyrosine phosphorylation of IRS-1/2 via PTP-1B. 
Quercetin is a major flavonol abundantly found in plant products such as capers, 
lovage, apples, onions, and grapes that possesses antioxidative and antiinflammatory 
properties (13, 14). Recently, we showed that grape powder extract (GPE), which is rich 
in quercetin and to a lesser extent in rans-resveratrol (trans-RSV), attenuates markers of 
inflammation in human adipocytes (15) and macrophages (16) and insulin resistance in 
human adipocytes (15). Consistent with these in vitro data, quercetin reduced 
inflammation or insulin resistance in rodent models of obesity (17, 18). Trans-RSV is 
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another polyphenol (ie, a phytoalexin) found in GPE (16) that has antioxidative and 
antiinflammatory properties (19). In vitro, trans-RSV was recently reported to reduce 
inflammation via its suppression of ERK and NF-κB activity in a human mast cell line 
(20). In vivo, trans-RSV has been reported to reduce hyperglycemia or hyperlipidemia in 
obese mice fed a high-fat diet (21, 22). 
However, the protective effects of quercetin and trans-RSV against inflammation 
and insulin resistance and their mechanism of action in primary human adipocytes are 
unclear. Furthermore, we do not know which polyphenols in our GPE attenuated 
inflammation or insulin resistance (15, 16). Therefo , we investigated the extent to 
which quercetin and trans-RSV attenuated TNF-α–mediated inflammation and insulin 
resistance in primary cultures of newly differentiated human adipocytes. 
 
Materials and Methods 
Materials 
All cell culture ware was purchased from Fisher Scientific (Norcross, GA). 
Adipocyte medium (AM-1) was purchased from Zen Bio Inc (Research Triangle Park, 
NC). Tri-Reagent was purchased from Molecular Research Center (Cincinnati, OH). 
Gene-specific primers were purchased from Applied Biosystems (Foster City, CA). Goat 
polyclonal antibody for anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 
mouse monoclonal antibody for anti-PPARγ were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA). Anti-phospho (Thr202/Tyr204) and -total ERK, anti-
phospho (Thr183/Tyr185) and -total JNK, anti-phospho (Ser63) and -total c-Jun, anti-
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phospho (Ser307) and -total IRS-1, and anti-inhibitory κB protein (IκBα) rabbit 
polyclonal antibodies were purchased from Cell Signaling Technologies (Beverly, MA). 
Immunoblotting buffers and precast gels were purchased from Invitrogen (Carlsbad, CA). 
Western Lightning Plus Chemiluminescence Substrate and 2-[3H]deoxyglucose (2-DOG; 
25–50 Ci/mmol, no. NET54900) were purchased from Perkin-Elmer Life Science 
(Boston, MA). Trans-RSV (no. 70675, ≥ 98% purity) was purchased from Caymen 
Chemicals (Ann Arbor, MI). Quercetin (no.Q0125-dihydrate, ≥ 98% purity) and all other 
reagents or chemicals were purchased from Sigma Chemical Co (St Louis, MO) unless 
otherwise stated. 
 
Primary cultures of newly differentiated human adipocytes 
Abdominal WAT was obtained from nondiabetic, white, and African American 
women [age: 20-50 y; body mass index (in kg/m2), <32.0] during abdominoplasty. 
Approval was obtained from the Institutional Review Board at University of North 
Carolina-Greensboro and the Moses Cone Memorial Hospital in Greensboro, NC. Tissue 
was digested by using collagenase, and stromal vascular (SV) cells were isolated, 
proliferated, and induced to differentiate in adipocyte media (AM-1) plus 250 µmol 
isobutylmethylxanthine/L and 1 µmol thiazolidinedione rosiglitazone/L (BRL 49653; a 
gift from Per Sauerberg, Novo Nordisk A/S, Copenhagen, Denmark) for 3 d. Cultures 
were then grown in AM-1 only for 3-9 d. Cultures containing ~50% preadipocytes and 
~50% adipocytes, based on visual observations, were tr ated between day 6 and 12 of 
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differentiation. Each experiment was repeated at least twice at different times by using a 
mixture of cells from 3 subjects unless otherwise indicated. 
 
Analysis of quercetin and RSV accumulation in primary cultures of human 
adipocytes 
Primary human SV cells were seeded in 100-mm dishes at 3.2 x 106 per dish and 
differentiated for 6 d. On day 6, media were changed. Twenty-four hours later, cultures 
were treated with 30 µmol quercetin/L or trans-RSV/L. At 0, 1, 3, 8, and 24 h of 
incubation, cultures were washed with Hank’s Buffered Salt Solution (HBSS) twice and 
treated on ice with 150 µL lysis buffer (Cell Signaling Technologies) for 20 min and 
subsequently harvested. The protein content in cell lysates was measured by using 
bicinchoninic acid protein assay purchased from Pierce Biotechnology (Rockford, IL). 
Then, lysates were incubated with 100 µL of 0.1 mol ascorbic acid/L, 50 µL of 0.78 mol 
sodium acetate buffer/L (pH 4.8), and 50 µL β-glucuronidase (~100,000 units β-
glucuronidase/L, ≤1000 units sulfatase/mL) from Helix pomatia at 37 ºC for 8 h. The 
mixture was extracted twice with 0.5 mL ethyl acetat , and the pooled supernatant fluid 
was concentrated to dryness by using a Thermo Electron Savant SC110 SpeedVac system 
(Waltham, MA). The sample was reconstituted in 150 mL methanol:water (50:50, 
vol:vol), filtered through a 0.45-µm membrane purchased from Millipore (Bedford, MA) 
and then subjected to liquid chromatography interfaced with the time of flight mass 
spectroscopy (LC-TOFMS) analysis as described (23). 
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RNA isolation and real-time quantitative polymerase chain reaction 
Primary human SV cells were seeded in 35-mm dishes at 0.4 x 106 per dish and 
differentiated for 6 d. On day 6, the media were changed. Twenty-four hours later, 
cultures were pretreated with dimethyl sulfoxide (DMSO) vehicle (0) or 10, 30, or 60 
µmol quercetin/L or trans-RSV/L for 1 h and subsequently treated with or without 0.5 ng 
TNF-α/mL for 3 h. This 3-h treatment with TNF-α was chosen on the basis of the results 
of a pilot dose and time course study showing significant induction of inflammatory 
genes at 3 h (data not shown). After treatment, conditi ed culture media were harvested 
to determine inflammatory adipokine secretion as decribed in the next section. Next, 
cultures were harvested and total RNA was isolated by using Tri-Reagent according to 
the manufacturer’s protocol. For real-time quantitative polymerase chain reaction (qPCR), 
2.0 µg total RNA was converted into first-strand cDNA by using a high capacity cDNA 
Archive Kit (Applied Biosystems). qPCR was performed in an Applied Biosystems 7500 
FAST Real Time PCR System by using Taqman Gene Expression Assays. To account for 
possible variations related to cDNA input or the presence of PCR inhibitors, the 
endogenous reference gene GAPDH was simultaneously q antified for each sample, and 
the data were normalized accordingly. 
 
Analysis of inflammatory adipokine secretion 
The conditioned culture media were collected as described in the previous section 
(RNA isolation and real-time quantitative polymerase chain reaction) from cells 
pretreated with DMSO vehicle (0) or 10, 30, or 60 µmol quercetin/L or trans-RSV/L for 
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1 h and subsequently treated with or without 0.5 ng TNF-α/mL for 3 h. The 
concentrations of IL-6, IL-8, IL-1β, and monocyte chemoattractant protein (MCP)-1 were 
determined in the conditioned culture media by using the BioPlex Suspension Array 
System from Bio-Rad (Hercules, CA) following the manufacturer’s protocol as described 
(16). 
 
Immunoblotting 
Primary human SV cells were seeded in 35-mm dishes at 0.4 x 106 per dish and 
differentiated for 6 d. On day 6, the media were changed. Twenty-four hours later, 
cultures were pretreated with DMSO vehicle (0) or 10, 30, or 60 µmol quercetin/L or 
trans-RSV/L for 1 h and then treated with or without 0.5 ng TNF-α/mL for 15 min. This 
15-min treatment with TNF-α was chosen based on the results of a pilot dose and time 
course study showing significant activation of MAPK, c-Jun, and NF-κB at 15 min (data 
not shown). Immunoblotting was conducted as previously described (24). 
 
Transient transfections 
For measuring NF-κB activity, primary cultures of human adipocytes were 
transiently transfected with the NF-κB responsive luciferase reporter construct, pNF-κB-
luc, purchased from Stratagene (La Jolla, CA), by using the Amaxa nucleofector system 
purchased from Lonza (Walkersville, MD) as previously described (15). Briefly, on day 6 
of differentiation, ~1.2 x 106 adipocyte cultures from a 60-mm plate were trypsinized and 
resuspended in 100 µL Amaxa nucleofector solution (ie, cell line nucleof ctor kit V) and 
82 
 
mixed with 1 µg pNF-κB-luc and 25 ng plasmid renilla luciferase-cytomegalovirus 
(pRLCMV) for each sample. Electroporation was performed by using Amaxa 
nucleofector device (V-33 nucleofector program). Cells were replanted in a 96-well plate 
after a 10-min recovery in calcium-free Dulbecco’s modified Eagle’s medium (DMEM). 
After 24 h, transfected cells were pretreated with DMSO vehicle (0) or 3, 10, or 30 µmol 
quercetin/L or trans-RSV/L for 1 h and then treated with or without 100 ng TNF-α/mL 
for 24 h. This 24-h treatment with TNF-α was chosen based on the results of a pilot dose 
and time course study showing significant activation of pNF-κB-luc at 24 h (data not 
shown). For the measurement of PPARγ activity, primary cultures of human adipocytes 
were transiently transfected with the multimerized PPAR response element (PPRE) 
luciferase reporter construct, PPRE-X3-TK-luc (a gift from Susanne Mandrup, University 
of Southern Denmark), by using the Amaxa nucleofectr system from Lonza. On day 12 
of differentiation, ~1.2 x 106 adipocyte cultures from a 60-mm plate were trypsinized and 
resuspended in 100 µL Amaxa nucleofector solution (ie, cell line nucleof ctor kit V) and 
mixed with 2 µg PPRE-X3-TK-luc and 25 ng pRL-CMV for each sample. 
Electroporation was performed by using the Amaxa nucleofector device (V-33 
nucleofector program). After a 10-min recovery in calcium-free DMEM, transfected cells 
were treated with DMSO vehicle (0) or 10 ng TNF-α/mL with or without 3, 10, or 30 
µmol quercetin/L or trans-RSV/L and replated in a 96-well plate. After 24 h of the 
treatment, 0.1 µmol BRL 49653/L, a PPARγ ligand, was added to activate the PPRE 
luciferase reporter for 24 h. This dose and duration of TNF-α or BRL 49653 treatments 
were selected based on the results of a pilot dose and time course study showing 
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significant suppression of PPRE-X3-TK-luc by TNF-α and significant activation of 
PPRE-X3-TK-luc by BRL 49653 at 24 h (data not shown). Firefly luciferase activity was 
measured by using the Dual-Glo luciferase kit purchased from Promega (Madison, WI) 
and normalized to renilla luciferase activity from the co-transfected control pRL-CMV 
vector. All luciferase data were presented in relative light units as the ratio of firefly 
luciferase to renilla luciferase activity. 
 
Insulin-stimulated 2-DOG uptake 
Primary human SV cells were seeded in 12-well plates t 1.6 x 105 per well and 
differentiated for 12 d. On day 12, media were changed to serum free low glucose (5 
mmol/L) DMEM. Twenty four hours later, cultures were pretreated with DMSO vehicle 
(0) or 3, 10, or 30 µmol quercetin/L or trans-RSV/L for 1 h and then treated with or 
without 5 ng TNF-α/mL for 24 h. This 24-h treatment with TNF-α was chosen based on 
the results of a pilot dose and time course study showing significant suppression of 2-
DOG at 24 h (data not shown). Culture media were removed and replaced with 0.5 mL 
HBSS with or without 100 nmol human insulin/L for 10 min. After insulin preincubation, 
4 nmol 2-DOG/L (0.5 µCi per well) was added to each well and incubated a 37 ºC for 90 
min. Basal and insulin-stimulated 2-DOG uptakes were measured as described previously 
(24). 
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Statistical analysis 
Statistical analyses were performed by using one-factor analysis of variance 
(ANOVA) (JMP version 6.03; SAS Institute, Cary, NC) or by testing the main effects of 
TNF-α alone, quercetin alone, or trans-RSV alone and their interaction by using 2-factor 
ANOVA (JMP version 6.03). Tukey’s honestly significant difference tests were used to 
compute individual pairwise comparisons of means (P < 0.05). Data are expressed as 
means ± SEMs. 
 
Results 
Quercetin or trans-RSV is taken up by primary human adipocytes  
The polyphenol content of cultures treated with 30 µmol quercetin/L or trans- 
RSV/L for 0, 1, 3, 8, and 24 h is shown in Figure 4.1. Intracellular quercetin and trans-
RSV contents were highest after 1 h of incubation with either polyphenol and then 
declined thereafter. Thus, it appears that quercetin and trans-RSV are rapidly taken up by 
adipocytes. However, it is not possible to determine the relative rates of absorption of 
quercetin or trans-RSV from these data, because the quercetin or trans-RSV could be 
rapidly interacting with cellular targets, thereby eing transformed into other types of 
quercetin or trans-RSV metabolites or species that we did not have standards for 
measuring. Indeed, we detected some unknown peaks by LCTOFMS after treatment of 
quercetin or trans-RSV in primary human adipocytes. 
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Quercetin, and to a lesser extent trans-RSV, attenuate TNF-α–mediated 
inflammatory gene expression and protein secretion 
To investigate the protective effects of quercetin and trans-RSV on TNF-α–
induced inflammation in human adipocytes, cultures w re treated with 10, 30, or 60 µmol 
quercetin/L or trans-RSV/L for 1 h and then treated with 0.5 ng TNF-α/mL for 3 h to 
induce inflammatory gene expression and protein secretion. Quercetin decreased TNF-α–
induced IL-6, IL-1β, IL-8, and MCP-1 gene expression (Figure 4.2A) and IL-6, IL-8, and 
MCP-1 secretion (Figure 4.2B) in a dose-dependent manner. IL-1β protein in the media 
was undetectable in all of the treatments. Trans-RSV also reduced inflammatory gene 
expression (Figure 4.2C), but to a relatively lesser extent than quercetin for IL-6, IL-8, 
and IL-1β. Furthermore, only the lowest dose of trans-RSV decreased TNF-α–mediated 
IL-6 and IL-8 protein secretion, and only higher doses of trans-RSV decreased MCP-1 
protein secretion (Figure 4.2D). No visible signs of quercetin or trans-RSV cytotoxicity 
were noted (eg, no floating cells, no visual differences in the number of attached cells or 
protein concentrations, and no abnormal changes in cell morphology). 
 
Quercetin decreases TNF-α–mediated ERK and JNK activation to a greater extent 
than trans-RSV 
We investigated the effect of quercetin and trans-RSV on ERK and JNK 
phosphorylation, because the phosphorylation of MAPK plays a role in activating 
transcription factors that induce inflammatory gene expression. Pretreatment of the 
cultures with 10, 30, or 60 µmol/L quercetin decreased TNF-α–mediated phosphorylation 
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of ERK and JNK (Figure 4.3A). In contrast, only the 60 µmol/L concentration of trans-
RSV decreased TNF-α–mediated phosphorylation of JNK, and trans-RSV had no effect 
on ERK phosphorylation (Figure 4.3B). 
 
Quercetin and trans-RSV attenuate TNF-α–mediated c-Jun phosphorylation and 
IκBα degradation 
Next, we examined the ability of quercetin and trans-RSV to prevent the 
activation of c-Jun, a component of AP-1, and NF-κB, because of their ability to induce 
the transcription of inflammatory genes. Pretreatment with quercetin (Figure 4.4A) and 
trans-RSV (Figure 4.4B) suppressed the TNF-α–mediated phosphorylation of c-Jun and 
degradation of IκBα. Notably, quercetin (Figure 4.4C), but not trans-RSV (Figure 4.4D), 
decreased basal and TNF-α–stimulated NF-κB reporter activity.  
 
Quercetin and trans-RSV attenuate TNF-α–mediated suppression of mRNA 
concentrations of PPARγ target genes and PPARγ mRNA, protein, and activity 
levels 
Given the important role that PPARγ plays in regulating inflammation and insulin 
resistance, we examined the effect of quercetin andtrans-RSV on the mRNA 
concentrations of several PPARγ target genes and on PPARγ mRNA, protein, and 
activity levels in TNF-α–treated cultures. Pretreatment with quercetin attenuated TNF-α–
mediated suppression of mRNA concentrations of PPARγ and PPARγ target gene, 
adipocyte fatty acid-binding protein (aP2), but notadiponectin (Figure 4.5A). Consistent 
87 
 
with these data, quercetin attenuated the TNF-α–mediated suppression of PPARγ protein 
concentration (Figure 4.5B). Pretreatment with trans-RSV attenuated TNF-α–mediated 
suppression of mRNA concentrations of PPARγ, aP2, and adiponectin (Figure 4.5C) and 
the protein concentration of PPARγ (Figure 4.5D) in a dose-dependent manner. Finally, 
quercetin, and to a greater extent trans-RSV, blocked TNF-α–mediated suppression of 
the activity of a PPRE reporter construct (Figure 4.5E).  
 
Quercetin prevents TNF-α–mediated insulin resistance 
Last, we examined the ability of quercetin and trans-RSV to prevent insulin 
resistance in TNF-α–treated cultures. Insulin resistance was determined by measuring the 
phosphorylation of serine residue 307 on IRS-1 (Ser307-IRS-1), the induction of PTP-1B 
gene expression, and reductions in insulin-stimulated 2-DOG uptake. Pretreatment of 
quercetin decreased TNF-α–mediated phosphorylation of Ser307-IRS-1 (Figure 4.6A) 
and PTP-1B gene expression (Figure 4.6B), and increased insulin-stimulated 2-DOG 
uptake (Figure 4.6C). Although trans-RSV decreased TNF-α–mediated phosphorylation 
of Ser307-IRS-1 (Figure 4.6D), it had no effect on PTP-1B expression (Figure 4.6E) or 
insulin-stimulated 2-DOG uptake (Figure 4.6F). Collectively, these data demonstrate that 
quercetin prevents TNF-α–mediated insulin resistance in primary cultures of newly 
differentiated human adipocytes, possibly by inhibiting upstream mediators of 
inflammation and their downstream negative regulators of insulin signaling.  
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Discussion 
In this study, we reported the protective effects of quercetin, and to a lesser extent 
trans-RSV, on TNF-α–mediated activation of upstream inflammatory cascades that 
induce inflammatory adipokines and negative regulators of insulin signaling and 
antagonize PPARγ in primary cultures of newly differentiated human dipocytes. We 
showed that 1) quercetin and trans-RSV are taken up by primary human adipocytes 
(Figure 4.1); 2) quercetin, and to a lesser extent trans-RSV, attenuated TNF-α–induced 
inflammatory gene expression and protein secretion (Figure 4.2); 3) quercetin attenuated 
TNF-α–mediated activation of inflammatory MAPK (Figure 4.3) and transcription 
factors (Figure 4.4) to a greater extent than trans-RSV; 4) quercetin and trans-RSV 
attenuated TNF-α–mediated suppression of PPARγ mRNA, protein, and activity levels 
(Figure 4.5); and 5) quercetin prevented TNF-α–mediated insulin resistance (Figure 4.6) 
in primary human adipocytes. On the basis of these data, we proposed a working model 
in Figure 4.7 by which quercetin and trans-RSV attenuated TNF-α–mediated 
inflammation and insulin resistance. 
To our knowledge, this is the first study to show that quercetin and trans-RSV 
aglycones are taken up by primary human adipocytes (Figure 4.1). Consistent with our 
data, quercetin was detected in human hepatocarcinoma HepG2 cells after treatment of 
red grape juice (25) and in human intestinal Caco-2 ells after treatment of whole onion 
and apple peel extracts (26). These studies support s eculation that significant amounts of 
quercetin glucosides may not exist in circulation, because of β-glucosidase hydrolysis of 
quercetin glucosides that occurs when they are absorbed across the intestine and pass 
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through the liver (26, 27). Because of these issues, w  used quercetin instead of quercetin 
glucosides to test its ability to prevent inflammation and insulin resistance. In contrast, 
other researchers have questioned the significance of in vitro studies performed with 
unconjugated polyphenols, arguing that they may not circulate in vivo due to extensive 
conjugation in the intestinal wall and the liver (28). However, several in vitro studies 
showed that quercetin and trans-RSV aglycones are absorbed by passive diffusion in 
Caco-2 cells (29) and HepG2 cells (30), respectively. Here, we provide data showing that 
quercetin and trans-RSV aglycones are taken up by primary human adipocytes. 
Several potential mechanisms by which quercetin and trans-RSV blocked TNF-
α–mediated inflammation or insulin resistance in adipocytes include 1) interfering with 
TNF-α receptor (TNFR) binding, 2) suppressing TNF-α–TNFR signaling, or 3) altering 
the activity of proteins involved in inflammation or glucose and lipid metabolism (Figure 
4.7). TNF-α causes inflammation and insulin resistance by activ ting key inflammatory 
pathways, including MAPK, NF-κB, and AP-1. Together, these proteins antagonize the 
ability of PPARγ to transcriptionally induce target genes such as the insulin-sensitive 
glucose transporter 4, aP2, lipoprotein lipase, perili in, and adiponectin, proteins 
essential for glucose and fatty acid disposal. Proposed mechanisms by which these 
inflammatory signals reduce PPARγ activity include 1) decreased PPARγ mRNA or 
protein concentrations; 2) increased phosphorylation of serine residue 112 on PPARγ by 
ERK, which leads to ubiquination and proteosome degradation; and 3) decreased PPARγ 
DNA binding and transcriptional activity (31). Consistent with these mechanisms, we 
found that quercetin or trans-RSV attenuated TNF-α–mediated activation of MAPK 
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(Figure 4.3), AP-1, and NF-κB (Figure 4.4) and suppression of PPARγ (Figure 4.5) and 
insulin signaling (Figure 4.6). However, we do not know whether quercetin or trans-
RSV directly silences these activators of inflammation or indirectly silences them by 
activating PPARγ, which is known to antagonize NF-κB and AP-1 (32). Indeed, PPARγ 
agonists such as thiazolidinedione reduce insulin resistance or inflammation associated 
with obesity. Notably, several studies have reported that polyphenols increase PPARγ 
expression or activity (33, 34). Thus, quercetin and trans-RSV may attenuate 
inflammation or insulin resistance by directly interfering with TNF-α signaling or 
indirectly by activating PPARγ. 
Another potential mechanism by which quercetin or trans-RSV prevents 
inflammation and insulin resistance is via inhibition of TNF-α–mediated reactive oxygen 
species (ROS) production (35). ROS increases inflamm tory gene expression by 
activating redox-sensitive proteins such as apoptosis ignal-regulating kinase-
1/thioredoxin (36) and redox-sensitive transcription factors such as AP-1, NF-κB, and 
NF-E2-related factor-2 (37). Moreover, increased ROS production by NAPDH oxidase 
and decreased antioxidative enzymes such as superoxid  dismutase and glutathione 
peroxidase contribute to obesity-associated inflammtion and insulin resistance (38). 
Trans-RSV has been shown to attenuate inflammation by inducing gene expression of 
antioxidative enzymes including heme oxygenase-1, superoxide dismutase, and 
glutathione peroxidase (37). Recently, Sakurai et al (39) showed that oligomerized grape 
seed polyphenols decrease inflammation by suppressing ROS production and NF-κB 
activation. Other polyphenols such as anthocyanins prevented inflammation by inhibiting 
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TNF-α–stimulated ROS production (40). Future studies are ne ded to investigate these 
potential mechanisms. 
One notable finding of this study was that quercetin xerted relatively stronger 
preventive effects than did trans-RSV. For example, quercetin showed greater capacity 
than trans-RSV to attenuate TNF-α–mediated inflammatory adipokine expression and 
secretion, MAPK and NF-κB activation, and insulin resistance. Similarly, Lee t al (41) 
reported that red wine extract and quercetin, but not trans-RSV, prevented TPA-induced 
carcinogenesis in mouse skin epidermal cells by inhib ting MAPK signaling pathway. 
Notably, our previous data showed that GPE containing quercetin and trans-RSV 
prevented inflammation and insulin resistance in TNF-α–treated primary human 
adipocytes (15). In addition, several studies suggested that combinations of quercetin, 
trans-RSV, or other polyphenols have additive effects on antioxidative activity in human 
erythrocytes (42), antiproliferation in C6 rat glioma cells (43) and in MDA-MB-231 
human breast cancer cells (44), and antiadipogenesis in mouse 3T3-L1 adipocytes (45, 
46). However, the contribution of combined grape poly henols such as quercetin and 
trans-RSV on prevention of inflammation and insulin resistance is unknown. Therefore, 
future studies will investigate 1) additive or synergistic effects of quercetin, trans-RSV, 
or other polyphenols found in our GPE on prevention of TNF-α–mediated inflammation 
and insulin resistance in vitro and 2) antiinflammatory and antidiabetic effects of GPE 
polyphenols in diet-induced obese animal models or in verweight or obese humans. 
In contrast with our findings, 2 studies reported that quercetin decreased insulin-
stimulated glucose uptake (47, 48). Nomura et al (47) used mature adipocytes from a 
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differentiated murine cell line and found that a 1-h treatment with quercetin decreased 
glucose uptake. Strobel et al (48) used freshly isolated rat adipocytes and found that a 30-
min treatment with quercetin decreased glucose uptake. In contrast, we found that 25-h 
treatment with quercetin prevented TNF-α from suppressing glucose uptake. Differences 
in these studies and ours include the use of 1) a murine cell line or freshly isolated murine 
adipocytes compared with human primary adipocytes, 2) very short treatment durations 
with quercetin (ie, 30–60 min) compared with a longer term treatment (ie, 25 h), and 3) 
nonstimulated cells compared with TNF-α–stimulated cells. 
Concentrations of quercetin (49-51) and RSV (52) found in the circulation after 
consumption of food rich in these polyphenols vary markedly, ranging from not 
detectable to 10 µmol/L. Furthermore, recent clinical trials showed that plasma 
concentrations of quercetin (53) and RSV (54) varied widely after supplementation, even 
though supplementation was shown to reduce inflammation in many in vivo models (17, 
18, 21, 22, 49). Notably, consuming whole foods or supplements rich in phytochemicals 
such as quercetin and RSV provide many important healt  benefits. These benefits are 
most likely due to their ability to attenuate oxidat ve stress and inflammation (37), as 
shown in the current study and in other in vitro studies (15, 16, 19, 20, 25, 34, 39-42, 55). 
In summary, these data indicate that quercetin and trans-RSV aglycones are taken 
up by primary human adipocytes and that quercetin is equally or more effective than 
trans-RSV in attenuating TNF-α–mediated inflammation and insulin resistance. Potential 
mechanisms for these antiinflammatory actions include direct effects (eg, suppression of 
the activation of ERK, JNK, c-Jun, and NF-κB, which induce inflammatory gene 
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expression and protein secretion) and indirect effects (eg, activation of PPARγ activity). 
Limitations of these in vitro studies include 1) testing mixed cell populations instead of 
testing each cell type separately (eg, preadipocytes and adipocytes), 2) lack of available 
information about the subjects providing the fat specimens, and 3) the high doses of 
quercetin and trans-RSV used. In vivo studies are needed to confirm these in vitro effects 
of quercetin and RSV on glucose metabolism and insulin resistance. 
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Figure 4.1. Quercetin (QUE) and trans-resveratrol (Trans-RSV) are taken up by 
primary human adipocytes. Cultures of newly differentiated human adipocytes (day 7) 
were supplemented with 30 µmol QUE/L (A) or trans-RSV/L (B) for 0, 1, 3, 8, and 24 h. 
Cultures were then harvested to determine the amount f QUE or trans-RSV that 
accumulated in adipocytes by liquid chromatography interfaced with time-of-flight mass 
spectroscopy analysis. All data were analyzed by using one-factor ANOVA and Tukey’s 
honestly significant difference tests. Mean (±SEM) values with different lowercase letters 
are significantly different, P < 0.05 (n = 2-3). Data are representative of 2 independent 
experiments. 
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Figure 4.2. Quercetin (QUE), and to a lesser extent trans-resveratrol (Trans-RSV), 
attenuate tumor necrosis factor-α (TNFα)–mediated inflammatory gene expression 
and protein secretion. Cultures of newly differentiated human adipocytes (day 7) were 
pretreated with dimethyl sulfoxide vehicle (0) or 10, 30, or 60 µmol QUE/L (A and B) or 
trans-RSV/L (C and D) for 1 h and were then treated with (filled squares or filled bars) 
or without (open circles or open bars) 0.5 ng TNF-α/mL for 3 h. Cultures and culture 
media were then harvested to determine mRNA concentrations of interleukin (IL)-6, IL-
1β, IL-8, and monocyte chemoattractant protein-1 (MCP-1) by quantitative polymerase 
chain reaction (A and C) and protein concentrations of IL-6, IL-8, and MCP-1 in media 
by using Bio-Rad’s Multi-Plex System (Hercules, CA; B and D). Data were analyzed by 
using one-factor (B and D) or 2-factor (A and C) ANOVA and Tukey’s honestly 
significant difference tests. A and C: Mean (±SEM) values with different lowercase 
letters are significantly different, P < 0.05 (n = 3). Data are representative of 3 
independent experiments. B and D: Mean (±SEM) values with different lowercase letters 
are significantly different, P < 0.05 (n = 4). Data are representative of 2 independent 
experiments. GAPDH, glyceraldehyde 3-phosphate dehyrogenase; NT, no treatment 
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Figure 4.3. Quercetin (QUE) attenuates tumor necrosi  factor-α (TNFα)–mediated 
extracellular signal-related kinase (ERK) and c-Jun-NH2 terminal kinase (JNK) 
activation to a greater extent than does trans-resveratrol (Trans-RSV). Cultures of 
newly differentiated human adipocytes (day 7) were pr treated with dimethyl sulfoxide 
vehicle (0) or 10, 30, or 60 µmol QUE/L (A) or trans-RSV/L (B) for 1 h and were then 
treated with (+) or without (–) 0.5 ng TNF-α/mL for 15 min. Cultures were then 
harvested to determine the protein concentrations of ph spho (p) or total ERK and JNK 
by immunoblotting. Data are representative of 3 independent experiments. 
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Figure 4.4. Quercetin (QUE) and trans-resveratrol (Trans-RSV) attenuate tumor 
necrosis factor-α (TNFα)–mediated c-Jun (cjun) activation and inhibitory κB 
protein (IκBα) degradation. A and B: Cultures of newly differentiated human 
adipocytes (day 7) were pretreated with dimethyl sulfoxide (DMSO) vehicle (0) or 10, 30, 
or 60 µmol QUE/L (A) or trans-RSV/L (B) for 1 h and were then treated with (+) or 
without (–) 0.5 ng TNFα/mL for 15 min. Cultures were then harvested to determine the 
protein concentrations of phospho (p) or total c-Jun, IκBα, and glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) by immunoblotting. C and D: Cultures were 
transfected on day 6 with pNF-κB-luc and pRL-CMV. Twenty-four hours later, 
transfected cells were pretreated with DMSO vehicle (0) or 3, 10, or 30 µmol QUE/L (C) 
or trans-RSV/L (D) for 1 h and were then treated with (filled bars or +) or without (open 
bars or –) 100 ng TNF-α/mL for 24 h. Firefly luciferase activity was measured and 
normalized to renilla luciferase activity from the co-transfected control pRL-CMV vector. 
A and B: Data are representative of 3 independent experiments. C and D: Data were 
analyzed by using 2-factor ANOVA and Tukey’s honestly ignificant difference tests. 
Mean (±SEM) values with different lowercase letters a e significantly different, P < 0.05 
(n = 4-6). Data are representative of 2 independent experiments. RLU, relative light unit; 
NF-κB, nuclear factor-κB 
98 
 
  
 
 
 
 
 
Figure 4.5. Quercetin (QUE) and trans-resveratrol (Trans-RSV) attenuate tumor 
necrosis factor-α (TNFα)–mediated suppression of peroxisome proliferator-
activated receptor γ (PPARγ) and PPARγ target gene expression, protein 
concentrations, and transcriptional activity. A-D: Cultures of newly differentiated 
human adipocytes (day 12) were pretreated with dimethyl sulfoxide (DMSO) vehicle (0) 
or 3, 10, or 30 µmol QUE/L (A and B) or trans-RSV/L (C and D) for 1 h and were then 
treated with (filled bars or +) or without (open bars or –) 5 ng TNF-α/mL for 24 h. 
Cultures were then harvested to determine them RNA concentrations of PPARγ and 
PPARγ targets [ie, adipocyte fatty acid-binding protein (aP2) and adiponectin] by 
quantitative polymerase chain reaction and the protein concentrations of PPARγ by 
immunoblotting. E: Cultures were transfected on day 12 with pTK-PPRE33-luc and pRL-
CMV and were then treated with DMSO vehicle (0) or 3, 10, or 30 µmol QUE/L or 
trans-RSV/L with (+) or without (–) 10 ng TNF-α/mL for 24 h. Cultures were then 
supplemented with (filled bars) or without (open bars) 0.1 µmol BRL49653/L (ie, 
rosiglitazone) for 24 h. Firefly luciferase activity was measured and normalized to renilla 
luciferase activity from the co-transfected control pRL-CMVvector. A, C, and E: Data 
were analyzed by using one-factor ANOVA and Tukey’s honestly significant difference 
tests. A and C: Mean (±SEM) values with different lowercase letters are significantly 
different, P < 0.05 (n = 3). Data are representative of 3 independent experiments. B and D: 
Data are representative of 3 independent experiments. E: Mean (±SEM) values with 
different lowercase letters are significantly different, P < 0.05 (n = 4-6). Data are 
representative of 2 independent experiments. BRL 49653 was a gift from Per Sauerberg; 
Novo Nordisk A/S. RLU, relative light unit; NT, no treatment; GAPDH, glyceraldehyde 
3-phosphate dehydrogenase 
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Figure 4.6. Quercetin (QUE) prevents tumor necrosis factor-α (TNFα)–mediated 
insulin resistance to a greater extent than does trans-resveratrol (Trans-RSV). A, B, 
D, and E: Cultures of newly differentiated human adipocytes (day 7) were pretreated with 
dimethyl sulfoxide (DMSO) vehicle (0) or 10, 30, or 60 µmol QUE/L (A and B) or trans-
RSV/L (D and E) for 1 h and were then treated with (filled squares or +) or without (open 
circles or –) 0.5 ng TNF-α/mL for 15 min to determine the protein concentration of serine 
residue 307 phosphorylation of insulin receptor substrate-1 (IRS-1; p-IRS-1-Ser307) by 
immunoblotting (A and D) or for 3 h to determine the mRNA concentration of protein 
tyrosine phosphatase-1B (PTP1B) by quantitative polymerase chain reaction (B and E). 
C and F: Cultures (day 13) were pretreated with DMSO vehicl  (0) or 3, 10, or 30 µmol 
QUE/L (C) or trans-RSV/L (F) for 1 h and were then treated with or without 5 ng TNF-
α/mL for 24 h. Subsequently, insulin-stimulated 2-[3H]deoxyglucose (2-DOG) uptake 
was measured after a total 100 min of incubation with (f lled bars) or without (open bars) 
100 nmol insulin/L. B and E: Data were analyzed by using 2-factor ANOVA and 
Tukey’s honestly significant difference tests. Means (±SEM) values with different 
lowercase letters are significantly different, P < 0.05 (n = 3). C and F: Data were 
analyzed by using one-factor ANOVA and Tukey’s honestly significant difference tests. 
Mean (±SEM) values with different lowercase letters a e significantly different, P < 0.05 
(n = 4). A-F: Data are representative of 3 independent experiments. NT, no treatment; 
GAPDH, glyceraldehyde 3-phosphate dehydrogenase 
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Figure 4.7. Working model on how quercetin (QUE) and trans-resveratrol (Trans-
RSV) block tumor necrosis factor-α (TNFα)–mediated inflammation or insulin 
resistance. Treating primary cultures of newly differentiated human adipocytes with 
QUE or trans-RSV prevents TNF-α from directly activating extracellular signal-related 
kinase (ERK), c-Jun-NH2 terminal kinase (JNK), c-Jun, and nuclear factor-κB (NF-κB), 
which are potent inducers of inflammatory gene exprssion and protein secretion and 
negative regulators of insulin signaling. In addition, QUE or trans-RSV may indirectly 
prevent inflammation and insulin resistance by increasing peroxisome proliferator-
activated receptor γ (PPARγ) activity, thereby antagonizing NF-κB or activator protein-1 
(AP-1) transcriptional activation of inflammatory genes and negative regulators of insulin 
signaling. Together, these block TNF-α–mediated induction of inflammatory cascades 
and suppression of insulin signaling necessary for glucose transporter 4 (GLUT4) 
translocation to the plasma membrane. TNFR, TNF-α receptor; IRS, insulin receptor 
substrate; IL, interleukin; MCP-1, monocyte chemoattrac ant protein-1; P, 
phosphorylated; Ub, ubiquinated; aP2, adipocyte-specific fatty acid binding protein; 
ATF-2, activating transcription factor 2; PTP-1B, protein tyrosine phosphatase-1B; IκBα, 
inhibitory κB protein 
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CHAPTER V 
 
BIOAVAILABILITY, GLUCOSE DISPOSAL RATE, AND ANTI-INFLAMMATORY 
PROPERTIES OF GRAPE POWDER IN HIGH FAT-FED OBESE MICE 
 
 
Abstract 
We reported that grape powder extract (GPE) from grape powder (GP) attenuated 
inflammation and insulin resistance in primary human adipocytes. However, we do not 
know if these results can be reproduced in vivo. Therefore, we examined 1) which 
polyphenol metabolites in GPE were bioavailable, 2) the impact of GP and GPE on 
insulin resistance and inflammation in high fat-fed mice, and 3) if a bioavailable 
polyphenol in GPE decreases markers of inflammation in human adipocytes. In 
experiment 1, C57BL/6J mice were gavaged with GPE and serum polyphenols were 
measured over time. In experiment 2, mice were fed high-fat diets supplemented with 3% 
GP or 0.02% GPE for 18 wk and markers of insulin resistance and inflammation were 
measured. In experiment 3, human adipocytes were treated with the bioavailable 
polyphenol quercetin 3-O-glucoside (Q3G) and markers of inflammation were measured. 
Serum Q3G increased at 1 h post-GPE gavage and decreas d thereafter. GP 
supplementation improved glucose disposal rate at 5 wk, and decreased serum levels of 
TNFα and monocyte chemoattractant protein-1 (MCP-1) and mRNA levels of 
inflammatory genes in adipose tissue at 18 wk. In co trast, GPE had no impact on these 
outcomes. Q3G attenuated TNFα-mediated MCP-1 and IL-1β expression in human 
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adipocytes, possibly by suppressing c-Jun-NH2 terminal kinase and c-Jun activation. In 
summary, 1) Q3G is a bioavailable polyphenol in GPE, 2) GP acutely improves glucose 
disposal rates and chronically reduces markers of inflammation in high-fat-fed obese 
mice, and 3) Q3G reduces several markers of inflammtion in human adipocytes.  
 
Introduction 
Obesity is the most prevalent nutrition-related healt  problem worldwide, with 1.5 
billion adults and 43 million children under the age of five classified as overweight and 
more than 500 million people classified as obese (1). Obesity is caused by a positive 
energy balance due to overconsumption of calories relative to energy expenditure that 
leads to the expansion of white adipose tissue (WAT) mass. Enlarged WAT is associated 
with a progressive infiltration and accumulation of macrophages that contribute to a 
chronic, low grade inflammation (2, 3). Moreover, several studies demonstrated that 
increased pro-inflammatory cytokines such as tumor necrosis factor alpha (TNFα; 4) or 
interleukin-6 (IL-6; 5, 6) and chemokines such as monocyte chemoattractant protein-1 
(MCP-1; 7-9) play an important role in the development of obesity-mediated insulin 
resistance and type 2 diabetes.    
Two strategies to suppress WAT expansion and obesity-mediated inflammation 
and insulin resistance are reduced caloric consumption and increased physical activity 
(10, 11). However, long term lifestyle changes such as caloric restriction and exercise are 
usually poorly maintained. Also, pharmacological and surgical interventions to treat 
obesity and metabolic diseases, while effective, have considerable side effects and 
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financial costs (12). Therefore, alternative strategies for suppressing obesity-associated 
inflammation and insulin resistance are needed. One potential dietary strategy is 
consuming grapes or grape products (e.g., wine, grape juice, powder, extract, raisins), 
which are rich in phenolic compounds that possess anti-oxidant and anti-inflammatory 
properties. Indeed, human, rodent, and cell studies (13, 14) support anti-inflammatory 
and anti-diabetic effects of grape products including grape powder (GP) or grape powder 
extract (GPE). However, the bioactive compounds in grape products are unclear, and 
mechanisms by which these products prevent inflammation or insulin resistance are 
debatable.  
Recently, our group reported that GPE isolated from GP rich in quercetin 
obtained from the California Table Grape Commission attenuated inflammation in human 
macrophages (15) and adipocytes (16) and insulin resistance in primary human 
adipocytes (16). We also showed that quercetin aglycone repressed inflammation in 
human macrophages (17) and adipocytes (18) and insulin resistance in human adipocytes 
(18). However, we did not know whether these in vitro effects could be reproduced in 
vivo. Also, the polyphenol metabolite profile in circulation following the consumption of 
GPE or GP was unknown. Therefore, the objective of this study was to determine 1) 
which polyphenols in GPE were absorbed in mice, 2) the effect of GPE and GP on 
inflammation and insulin resistance in a diet-induced, obese mouse model, and 3) the 
extent to which a bioavailable grape polyphenol suppressed markers of inflammation in 
primary human adipocytes.    
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Research Design and Methods 
Preparation of GP and GPE 
 Lyophilized GP, obtained from red, green and blue-p rple seeded and seedless 
California grapes, was provided by the California Table Grape Commission in aluminum 
bags. The GP was extracted to remove the sugars (90% wt:wt) in the laboratory of Dr. 
Wei Jia at the University of North Carolina at Greensboro (UNCG) Center for Research 
Excellence in Bioactive Food Components in Kannapolis, NC. To remove the sugars, a 
Diaion HP-20 anion resin column was used to elute the extract from the column using 
methanol, and then it was lyophilized to make the final GPE (19). Then, the polyphenol 
compositions of GP and GPE (Table 5.1) were analyzed using an Agilent liquid 
chromatography time-of-flight mass spectrometry (HPLC-TOFMS; Agilent, Santa Clara, 
CA) as previously described (15).   
 
Experiment 1-Gavaging mice with GPE  
Male, 12 wk old C57BL/6J mice (n=32), weighing approximately 30 g, were 
obtained from Jackson Laboratories (Bar Harbor, ME) and housed individually in a 12 h 
light/12 h dark cycle, temperature-controlled room. Ethical treatment of animals was 
assured by the UNCG Institutional Animal Care and Use Committee. Mice were 
acclimated to a low-fat purified diet (#D12450B from Research Diets, New Brunswick, 
NJ) for 10 d containing casein as the protein source devoid of phytoestrogens or other 
phytochemicals. Subsequently, mice were deprived of food for 6 h and then 8 mice were 
gavaged with water only (1% carboxymethylcellulose sodium salt; CMC; Sigma-Aldrich, 
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St. Louis, MO) for the 0 h time point or 24 mice were gavaged with GPE (1 g/kg body 
weight, dissolved in a 1% CMC water solution; 1 g GPE per 10 mL). Mice were then 
anesthetized by isoflurane inhalation at 0 (water control), 1, 3, or 8 h post-GPE gavage. 
Blood was collected by orbital sinus puncture into a Vacutainer tube (BD Vacutainer 
Systems, Franklin Lakes, NJ). Serum was obtained by centrifugation at 1100 x g for 10 
min at 4°C and immediately stored at -80°C prior to polyphenol profile analysis.   
 
Analysis of serum polyphenols  
 Serum polyphenol levels were measured by a UPLC-MS/MS system (ACQUITY 
UPLC-Quattro Premier XE MS, Waters Corp., Milford, MA) as described below using a 
modification of the method of Day et al. (20). Briefly, each serum sample (200 µL) of 
mice was acidified to pH 3 with 20% aqueous formic acid (10 µL; Thermo Fisher 
Scientific, Fair lawn, NJ). Then, 2 g/L ascorbic acid (20 µL; Sigma-Aldrich, St. Louis, 
MO) was added to prevent oxidation during sample prepa ation and 60 mmol/L apigenin 
(10 µL; Chromadex, Irvine, CA) was added to the serum as internal standard (I.S.). 
Acetonitrile (600 µL) was used to precipitate plasm proteins and extract flavonol 
metabolites. The samples were vortexed (VWR digital vortex mixer, VWR International, 
West Chester, PA) for 30 s every 2 min over 10 min period. The mixture was centrifuged 
at 13,500 rpm for 20 min at 4.0 ± 0.5 °C (Microfuge 22R centrifuge, Beckman Coulter, 
Inc., Atlanta, GA). The supernatant was collected an  the pellet was re-extracted as 
described above but with methanol instead of acetonitrile. The acetonitrile and methanol 
supernatants were combined and reduced to dryness i CentriVap Vacuum Concentrator 
111 
 
(Labconco, Kansas City, MO). Extracts were dissolved in methanol (100 µL) plus 1% 
formic acid (100 µL) and then centrifuged at 13,500 rpm for 20 min (Allegra X-15R, 
Beckman Coulter, Inc., Atlanta, GA). The supernatant was filtered through a 13-mm 
syringe filter with a 0.2 µm PTFE membrane (Millipore Corp., Billerica, MA) before LC-
MS analysis. 
 
Linearity, Recovery 
 A total of 68 standards were analyzed. Each standard w s individually dissolved 
in methanol or water and prepared as stock solution at a concentration of 1 g/L. Each 
aliquot of standard stock solution was mixed to obtain a mixed stock solution. The 
resulting mixed solution was diluted at a series of concentration of 5.12, 2.56, 1.28, 0.64, 
0.32, 0.16, 0.08, 0.04, 0.02, 0.01, or 0.005 mg/L. The apigenin (I.S.) was added to the 
diluted solutions and the final concentration for I.S. is 150 µg/L. The calibration curve 
and the corresponding regression coefficients were obtained by I.S. adjustment. 
Quantification of polyphenols was performed by UPLC-MS/MS using a multiple reaction 
monitoring (MRM) mode. The concentration of each identified polyphenol was 
automatically calculated using the corresponding calibration curve in the MassLynx 
application manager, QuanLynx (Waters Corp., Milford, MA).  
 
Experiment 2-High fat-fed obese mice supplemented with GP and GPE 
 C57BL/6J mice (n=50) were obtained from Jackson Laboratories at 5 wk of age 
and housed individually in a 12 h light/12 h dark cycle, temperature-controlled room. 
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Ethical treatment of animals was assured by the UNCG Institutional Animal Care and 
Use Committee. After several days of acclimation, mice were randomly assigned to one 
of five dietary treatments (n=10 mice per treatment; Table 5.2) for 18 wk. Diets 
(Research Diets) were as follows: 1) a low-fat diet (LF) containing 10% of energy from 
fat, 2) a high-fat control diet (HF) containing 60% of energy from fat, 3) a HF diet 
supplemented with 0.02% (wt:wt) GPE (HFGE), 4) another high-fat control diet with a 
modified sugar content (HS) to control for the amount and type of sugar in GP, and 5) a 
high-fat diet supplemented with 3% (wt:wt) GP (HFGP). The sugar composition in GP 
was ~90%, and consisted of dextrose and fructose at 50:50 ratio (wt:wt; 19). Energy from 
sugars including sucrose, dextrose, and fructose wa adjusted in the LF, HF, and HS diets 
to be equivalent to energy from sucrose, dextrose, and fructose in the HFGE and HFGP. 
The amount of 0.02% GPE in the HFGE was based on the amount of total polyphenols in 
3% HFGP. Diets were packed under inert gas in indivdual 2.5 kg foil bags and stored at -
20°C until use. Fresh diet was provided twice per wek to minimize oxidization. Mice 
had ad libitum access to both food and water. Food intake and body weight were 
measured weekly. 
 
Intraperitoneal glucose tolerance tests (GTT)  
 GTT was performed at baseline, 5, 10, and 15 wk on non-anesthetized mice. Mice 
were deprived of food for 8 h and given an intraperitoneal glucose (Sigma-Aldrich) 
injection at a dose of 1 g/kg body weight. Blood was obtained from the tail vein and 
glucose levels were determined at 0, 5, 15, 30, 60 and 120 min following glucose 
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administration using Contour blood glucose monitoring system (Bayer Diabetes Care, 
Tarrytown, NY). Total GTT area under the curve (AUC) was calculated as described (21).  
 
Analysis of serum insulin and inflammatory cytokine and chemokine levels 
 Fasting serum insulin levels were determined at 12 wk using commercially-
available, enzyme-linked, immunosorbent assay (ELISA) kits according to the 
manufacturer's instructions (Crystal Chem, Downers G ove, IL). Serum TNFα and IL-6 
levels were determined at 18 wk using the Bio-Plex magnetic bead-multiplex 
immunoassay on the Bio-Plex 200 system according to the manufacturer’s instructions 
(Bio-Rad, Hercules, CA). Serum MCP-1 levels were determined at 18 wk using 
commercial ELISA kits according to the manufacturer’s instructions (R&D Systems, 
Minneapolis, MN). 
 
Tissue RNA analysis and real-time quantitative PCR (qPCR) 
 Skeletal muscle and WAT were harvested at 18 wk and total RNA from muscle 
was extracted using RNeasy Plus Universal Kit (Qiagen, Valencia, CA) and WAT was 
extracted using RNeasy Lipid Tissue Kit (Qiagen) combined with RNase-Free DNase Set 
(Qiagen). RNA integrity was assessed using Agilent RNA 6000 Nano Kit on an Agilent 
2100 Bioanalyzer (Agilent, Santa Clara, CA). For real-time qPCR, 2 µg total RNA from 
mouse tissues was converted into first-strand cDNA by using a high-capacity cDNA 
Archive Kit (Applied Biosystems, Foster City, CA). The qPCR was performed in a 7500 
FAST Real Time PCR System by using Taqman Gene Expression Assays (Applied 
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Biosystems). Fold differences in gene expression were calculated as 2−∆∆Ct using the 
endogenous reference gene TATA-binding protein (TBP).  
 
Experiment 3-Primary cultures of human adipocytes treated with quercetin 3-O-
glucoside (Q3G)  
 Abdominal WAT was obtained from nondiabetic and nonobese Caucasian, and 
African American women [age: 20-50 y; body mass index (BMI in kg/m2) < 32.0] during 
abdominoplasty. Approval was obtained from the Institutional Review Board at UNCG 
and the Moses Cone Memorial Hospital in Greensboro, NC. Tissue was digested by using 
collagenase (Worthington, Lakewood, NJ), and stromal vascular (SV) cells were isolated, 
proliferated, and induced to differentiate in adipocyte media (AM-1; ZenBio, Research 
Triangle Park, NC) plus isobutylmethylxanthine (250 µmol/L; Sigma-Aldrich) and 
thiazolidinedione rosiglitazone (1 µmol/L; BRL 49653, a gift from Dr. Per Sauerberg, 
Novo Nordisk A/S, Copenhagen, Denmark) for 3 d. Cultures were then grown in AM-1 
only for 4 d. Cultures containing ~50% preadipocytes and ~50% adipocytes, based on 
visual observations, were treated at day 7 of differentiation. Each experiment was 
repeated at least three more times using a mixture of c lls from three subjects. 
 
Cell RNA analysis and qPCR 
 Primary human SV cells were seeded in 35-mm dishes at 0.4 × 106 per dish and 
differentiated for 7 d. On day 7, human adipocyte cultures were pretreated with DMSO 
vehicle (0) or 1.5 nmol/L or 3, 10, or 30 µmol/L of Q3G for 1 h and subsequently treated 
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with or without 20 ng/L of TNFα for 3 h. Total RNA from primary human adipocytes 
was extracted using RNeasy Mini Kits (Qiagen). RNA integrity was estimated as 
described above for tissue RNA. For real-time qPCR, 1 µg total RNA was converted into 
first-strand cDNA by using a high-capacity cDNA Archive Kit and qPCR was conducted 
as described above for tissue RNA. Fold differences in gene expression were calculated 
as 2−∆∆Ct using the endogenous reference gene glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH). 
 
Immunoblotting 
 Primary human SV cells were seeded in 35-mm dishes at 0.4 × 106 per dish and 
differentiated for 7 d. On day 7, primary human cultures were pretreated with DMSO 
vehicle (0) or 1.5 nmol/L or 10, 30, or 60 µmol/L of Q3G for 1 h and then treated with or 
without 20 ng/L of TNFα for 1 h. Immunoblotting was conducted as previously described 
(22). 
 
Statistics  
 Data are expressed as the mean ± the standard error of the mean (SEM). Data 
were analyzed using one-way ANOVA, followed by each pair of Student's t-tests for 
multiple comparisons. Differences were considered significant if P<0.05. All analyses 
were performed using JMP version 8.0 software (SAS Institute, Cary, NC). 
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Results 
Several quercetin metabolites rapidly appear in the serum of mice gavaged with 
GPE (Experiment 1) 
 To determine the bioavailability of grape polyphenols, mice were gavaged with 1 
g of GPE per kg body weight based on work by Tsang et al. (23). GPE traveled quickly 
through the gastrointestinal tract, as evidenced by visual examination of the movement of 
purple digesta through the gastrointestinal tract from 1-8 h, and the appearance of entirely 
purple feces at 8 h (Figure 5.1A). Six polyphenols increased in circulation post-GPE 
gavage (Figure 5.1B-G). However, only Q3G (Figure 5.1B) was significantly (P<0.0006) 
increased at 1 and 3 h compared to baseline. Rutin, another metabolite of quercetin, 
increased at 1 h post-GPE gavage, but this increase w  not significant (P=0.07).   
 
GP supplementation of a high-fat diet improves glucose disposal rates acutely and 
decreases markers of inflammation chronically (Experiment 2) 
 In order to determine the extent to which two sources of grape polyphenols (GP, 
GPE) prevented insulin resistance and chronic inflamm tion associated with diet-induced 
obesity, mice were fed high-fat diets containing 3%GP (HFGP) or 0.02% GPE (HFGE) 
for 18 wk. The 3% GP diet was chosen based on work by Seymour et al. (24, 25) 
demonstrating anti-inflammatory and cardioprotective effects of 3% GP treatment for 18 
wk in a Dahl Salt-Sensitive rat model of hypertensio . This level of GP is equivalent to 
nine daily human servings of fresh grapes, assuming 1 serving = ¾ cup grapes weighing 
126 g = 23 g of dried grape powder, and that a 30 g mouse eats ~3 g/d of food. The 
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0.02% GPE diet contained the same amount of total plyphenols as 3% GP diet. A high-
fat control diet (HF) contained the same amount of fat and sucrose as the HFGE diet and 
second high-fat control diet, HS, contained the same ount of fat and sugars (i.e., 50:50 
ratio of dextrose/fructose) as the HFGP diet (Table 5.2).  A low-fat diet (LF) was fed as a 
control for the HF, HFGE, HS, and HFGP diets (Table 5.2). 
 High fat-feeding impaired glucose disposal rate at 5, 10, and 15 wk (Figure 5.2A-
C), and decreased mRNA markers of glucose disposal in muscle and WAT at 18 wk 
(Figure 5.2D-E) and raised fasting glucose and insulin levels at 12 wk (Table 5.3)  
compared to the LF-feeding. Notably, the HFGP group had improved GTT at 30 and 60 
min and a lower AUC for the GTT (P<0.002) compared to their HS control group at 5 wk, 
suggesting better glucose disposal rates (Figure 5.2A). However, these beneficial effects 
of GP were not seen at 10 wk (Figure 5.2B) or 15 wk (Figure 5.2C), compared to their 
HS controls. Furthermore, fasting glucose and insul levels (Table 5.3) at 12 wk and the 
mRNA markers of glucose disposal in muscle (Figure 5.2D) and WAT (Figure 5.2E) at 
18 wk were not affected by feeding GP. Surprisingly, HFGE had no effect on glucose 
disposal rate at any time point (Figure 5.2A-C) or mRNA markers of glucose disposal at 
18 wk (Figure 5.2D-E) as well as fasting glucose and insulin levels at 12 wk (Table 5.3) 
compared to their HF control group.   
 Given the important role of macrophage recruitment and accumulation in WAT 
during the development of obesity-associated inflamm tion and metabolic diseases (26, 
27), we sought to determine the extent to which grape polyphenols attenuated markers of 
macrophage recruitment/accumulation and inflammatory cytokine and chemokine levels 
118 
 
in circulation and mRNA levels in WAT. We isolated four WAT depots including 
epididymal (bilateral intra-abdominal visceral fat depots attached to the epididymis), 
inguinal (bilateral superficial subcutaneous fat depots between the skin and muscle fascia 
just anterior to the lower segment of the hind limbs), mesenteric (a glue-like visceral net 
located in the mesenterium of the intestines), and retroperitoneal (bilateral visceral fat 
depots in abdominal cavity behind the peritoneum on the dorsal side of the kidneys) 
WAT. We found that the wet weights of the four WAT depots and liver at 18 wk (Table 
5.3) were lower in the LF group compared to all four high-fat groups; however, there 
were no significant differences between the HF control and HFGE groups (P>0.07) or the 
HS control and HFGP groups (P>0.1) at 18 wk (Table 5.3). Thus, feeding GP or GPE to 
HF-fed mice did not reduce WAT depot or liver weights. 
Although GP and GPE did not prevent HF-induced WAT expansion, we found 
that HFGP group had lower serum levels of TNFα (P=0.001) and MCP-1 (P=0.03) 
compared to the HS controls (Figure 5.3A). However, there were no differences in serum 
TNFα (P=0.09) and MCP-1 (P=0.2) levels in the HFGE group compared to HF group at 
18 wk (Figure 5.3A). Moreover, there were no differences in circulating interleukin (IL)-
6 levels in HFGP group compared to HS control group r HFGE group compared to HF 
control group at 18 wk (data not shown). Consistent with serum levels, the HFGP group 
had lower mRNA levels of TNFα (P=0.05), MCP-1 (P=0.002), and two markers of 
macrophage recruitment and accumulation, CD11c (P=0.03) and F4/80 (P=0.05), in 
epididymal WAT compared to the HS control group (Figure 5.3B). In contrast, there 
were not differences in the expression of these markers in epididymal WAT in the HFGE 
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group compared to the HF control group at 18 wk (Figure 5.3B). Finally, the HFGP 
group had lower mRNA levels of IL-6 (P=0.03), MCP-1 (P=0.02), interferon gamma-
induced protein 10 (IP-10; P=0.02), and F4/80 (P=0.003) in inguinal WAT compared to 
the HS controls (Figure 5.3C).  In contrast, there were no significant reductions in any of 
these markers in inguinal WAT in the HFGE group compared to the HF controls (Figure 
5.3C). 
 
Q3G attenuates several inflammatory markers in primary human adipocytes 
treated with TNFα (Experiment 3) 
To investigate the potential mechanism by which bioavailable grape polyphenols 
attenuate inflammation, we pretreated primary cultures of newly-differentiated human 
adipocyte with Q3G followed by acute treatment with TNFα, an inflammatory cytokine 
elevated in circulation and WAT of obese individuals (4) and in obese mice in this study. 
Cultures were treated with 1.5 nmol/L or 3, 10, or 30 µmol/L Q3G for 1 h and 
subsequently treated with 20 ng/L of TNFα for 1 h to determine activation of 
inflammatory mitogen-activated protein kinases including extracellular signal-related 
kinase (ERK) and c-Jun-NH2 terminal kinase (JNK) and their downstream transcription 
factors including nuclear factor (NF)-κB and cJun, respectively, or 3 h to determine 
inflammatory gene expression. The 1.5 nmol/L of Q3G and 20 ng/L of TNFα were 
chosen on the basis of the results of Experiment 1 and 2, respectively, showing serum 
levels of Q3G increased to 1.5 nmol/L at 1 h post-gavage with GPE (Figure 5.1B) and 
serum levels of TNFα increased to 20 ng/L in mice fed with high-fat diets for 18 wk 
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(Figure 5.3A). We found that Q3G at 10 or 30 µmol/L, but not at lower levels, attenuated 
TNFα-induced MCP-1 and IL-1β gene expression (Figure 5.4A) and modestly decreased 
JNK and c-Jun phosphorylation (Figure 5.4B). However, Q3G did not suppress TNFα-
mediated induction of other inflammatory genes (e.g., IL-6) or activation of ERK and 
NF-κB (data not shown). 
 
Discussion 
 We previously reported that GPE extracted from GP obtained from the California 
Table Grape Commission attenuated markers of inflamm tion in human adipocytes and 
macrophages that were associated with improved insulin ensitivity in human adipocytes 
(15, 16). However, we did not know whether these in vitro effects could be reproduced in 
vivo. Also, the profile of phenolic metabolites in circulation following the consumption 
of GPE or GP was unknown, and the extent to which these phenolic metabolites impacted 
diet-induced insulin resistance and chronic inflammation had not yet been established. 
Here, we reported that Q3G levels robustly increased in the serum of mice at 1 h post-
gavage with GPE and decreased thereafter. We found that high fat-fed mice 
supplemented with GP, but not GPE, had better glucose disposal rates at 5 wk, but not at 
10 or 15 wk, compared to controls. Notably, feeding GP, but not GPE, reduced markers 
of inflammation in circulation and in two WAT depots at 18 wk. Finally, the bioavailable 
polyphenol Q3G attenuated TNFα-mediated JNK and c-Jun activation and MCP-1 and 
IL-1β gene expression in primary human adipocytes. 
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 Several reports indicate that Q3G is not commonly present in the circulation, 
because of β-glucosidase hydrolysis of quercetin glucosides in the intestine and liver (20, 
28, 29). However, we detected a robust increase in Q3G levels in the mouse serum after 1 
h post-gavage with GPE. Indeed, Manach et al. (30) reviewed 97 human bioavailability 
studies and reported that quercetin glucosides might not be detected in plasma after oral 
administration at nutritionally-relevant levels. Therefore, it is possible that the robust 
peak in Q3G after 1 h of administration was due to the high dose administered as a bolus. 
As a bolus, quercetin glucosides may have passively diffused across or between 
enterocytes, escaping intestinal as well as hepatic β-glucosidase hydrolysis. Consistent 
with our data, cyanidin 3-O-glucoside and its metabolites such as methylated cyanidin 3-
O-glucosides were detected in the rat plasma after 30-60 min post-gavage with cyanidin 
3-O-glucosides (M.W. 484) at 0.9 mmol/l (0.44 g) per kg body weight (31). Interestingly, 
anthocyanins including cyanidin 3-O glucosides or malvidin 3-O-glucoside were present 
in relatively high and varied amounts in our GPE and GP (Table 5.1). However, 
anthocyanins or their metabolites were undetectable in our mouse serum samples within 
1-8 h after GPE gavage. Consistent with our data, several intervention studies reported 
that anthocyanins such as malvidin 3-O-glucoside were undetectable in the plasma of 
adult subjects after a single oral administration of red wine and red grape juice (32, 33). 
One possible explanation for this lack of detection of these metabolites is that they can be 
rapidly degraded or metabolized by the intestinal microflora or by freezing of urine or 
blood samples for storage (34). 
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The rapid rise in obesity is accompanied by a similar increase in insulin resistance 
and type 2 diabetes. For instance, ~90% of people with type 2 diabetes are overweight 
and ~50% are obese (35), suggesting a strong positive relationship between the two 
diseases. Here, we showed that mice fed a high fat diet (i.e., 60% energy from fat) 
supplemented with GP had improved glucose disposal rates acutely at 5 wk (Figure 
5.2A), but not chronically at 10 wk (Figure 5.2B) or 15 wk (Figure 5.2C). Consistent 
with our data, consumption of muscadine grape wine or dealcoholized grape wine (150 
mL/day) for 4 wk improved fasting blood glucose and i sulin levels in subjects with type 
2 diabetes (36). In contrast to our study, resveratrol, a polyphenol found in grapes and red 
wine, has been reported to improve glucose and lipid homeostasis in high fat-fed 
C57BL/6J obese mice during long term supplementation at 0.04% in the diet (wt:wt) for 
12-48 wk or 2.5-400 mg/kg body weight/day for 15-16 wk (37-39). Overall, multiple 
studies suggest that grape products have anti-diabetic effects due to their abundant 
polyphenol content and low glycemic index (40).  
An emerging feature of obese and type 2 diabetes is the r linkage with chronic, 
low-grade inflammation that begins in WAT and eventually becomes systemic. For 
instance, obese patients with type 2 diabetes have ele ated levels of TNFα (4) and MCP-
1 (9) in their WAT and blood. Our study showed that 3% GP, but not 0.02% GPE, 
attenuated the levels of TNFα and MCP-1 in circulation (Figure 5.3A) and WAT (Figure 
5.3B) at 18 wk. Consistent with our data, Dahl salt-sensitive, hypertensive rats 
supplemented with 3% GP in the diet (wt:wt) for 18 wk had lower plasma and cardiac 
levels of TNFα (24, 25). Nevertheless, we were surprised that GPE had no effect on 
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glucose intolerance acutely or on markers of inflammation chronically in obese mice, 
considering that the GPE diet had the same amount of total polyphenols as the GP diet. 
Furthermore, our in vitro studies using GPE (15, 16) and other in vivo studies using grape 
seed extract (41) reported inhibitory effects on inflammation or insulin resistance. This 
discrepancy may be due to loss of ~10% water insoluble polyphenols (e.g., quercetin 
aglycone) during the preparation of GPE from GP (42, 43). Indeed, quercetin aglycones 
were undetectable in our GPE (Table 5.1) as well as in circulation following GPE gavage. 
Thus, it suggests that whole fruits such as GP contain a greater variety of polyphenols or 
other phytochemicals than GPE that may play an important role in attenuating 
inflammation and improving glucose disposal rate in diet-induced obese mouse models. 
In our cell studies, we chose to examine the direct effects of Q3G in human 
primary adipocytes, because of their application to human obesity versus rodent obesity. 
However, using a murine primary adipocytes or immortalized adipocyte cultures (i.e., 
3T3-L1) might have been more applicable to our mouse studies. Sakurai et al. (44) 
reported that oligomerized grape seed polyphenol attenuated inflammatory TNFα and 
MCP-1 production in HW mouse white adipocytes co-cultured with a murine 
macrophage cell line (RAW264 cells). Here, we reported that Q3G attenuated 
inflammatory MCP-1 and IL-1β gene expression in human primary adipocyte cultures 
treated with TNFα (Figure 5.4A). It has been demonstrated that TNFα-induced MCP-1 
gene expression in adipocytes or other cell types occurs via activation of the transcription 
factors NF-κB or AP-1 (i.e., c-Jun, c-fos, ATF), because the promoter of MCP-1 gene 
contains NF-κB and AP-1 binding site (45-47). Indeed, we found that Q3G reduced 
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TNFα-mediated phosphorylation of JNK and downstream c-Jun activation (Figure 5.4B), 
but not ERK activation or IκBα degradation (data not shown), in human primary 
adipocyte cultures. Further investigations examining upstream activators of TNFα-
mediated inflammatory signaling are needed to understand how Q3G suppresses this 
pathway. 
In summary, our findings suggest that feeding GP equivalent to 9 daily human 
servings to high fat-fed mice improves glucose disposal rates acutely and markers of 
inflammation chronically without affecting body fat levels. In addition, Q3G may be one 
of the polyphenols in GP that contributes to these beneficial outcomes. Further mouse 
studies feeding a high-fat diet that more closely rsembles a typical western diet (i.e., 
34% of energy from fat) and clinical studies with overweight or obese individuals are 
needed to determine if these effects of GP or other grape products can be reproduced in 
humans.
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Table 5.1. Polyphenols in grape powder extract (GPE) and grape powder (GP)1 
 
 
1 1 kg of GP yielded 4 g of GPE = 0.4 % of initial weight 
2 Data are mean ± SEM 
3 Quercetin in GPE can be detected but was under the limit of detection 
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Table 5.2. Compositions of a low-fat (LF), high-fat (HF), HF plus grape powder extract 
(HFGE), HF with modified sugar content (HS), and HF plus grape powder (HFGP) diet 
 
 
1 Mineral mixture (S10026) contained the following (g/kg mineral mix): sodium chloride, 
259; magnesium oxide, 41.9; magnesium sulfate, 257.6; ammonium molybdate 
tetrahydrate, 0.3; chromium potassium sulfate, 1.925; copper carbonate, 1.05; sodium 
fluoride, 0.2; potassium iodate, 0.035; ferric citrate, 21; manganese carbonate hydrate, 
12.25; sodium selenite, 0.035; zinc carbonate, 5.6;sucrose, 399.105. Sucrose in the 
mineral mix provided 67 kJ/kg diet. 
2 Vitamin mixture (V10001) contained the following (/kg vitamin mix): vitamin A 
palmitate, 0.8; vitamin D3, 1; vitamin E acetate, 10; menadione sodium bisulfate, 0.08; 
biotin (1%), 2; cyanocobalamin (0.1%), 1; folic acid, 0.2; nicotinic acid, 3; calcium 
pantothenate, 1.6; pyridoxine-HCl, 0.7; riboflavin, 0.6; thiamin HCl, 0.6; sucrose, 978.42. 
Sucrose in the vitamin mix provided 164 kJ/kg diet. 
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Table 5.3. The effect of grape powder extract (GPE) or grape powder (GP) on mice fed with a high-fat (HF) or HF with 
modified sugar content (HS) diet, respectively, compared to low-fat (LF) controls. 
 
Data are means ± SEM, n = 7-9. Means in a row without a common letter differ, P < 0.05.
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Figure 5.1. Several quercetin metabolites were detected in serum of mice following 
oral administration of grape powder extract (GPE). Male C57BL/6J mice were 
gavaged with the water vehicle (controls, n=8) or 1 g/kg body weight of GPE (n=24). 
Immediately, blood samples were collected from vehicl  control mice (0 h). Then, blood 
samples were collected from mice that received the GPE bolus at 1, 3, or 8 h post-gavage. 
The movement and excretion of GPE (purple/dark color identified by an arrow) in the 
gastrointestinal tract and feces (A). The concentration (nmol/L) of quercetin 3-O-
glucoside (B), rutin (C), myricetin (D), peonidin 3-O-glucoside (E), epigallocatechin (F), 
and procyanidin A2 (G) in mouse serum was measured using a UPLC-MS/MS system. 
Data were analyzed using one-way ANOVA and Student’s t ests. Means ± SEM (n=8) 
without a common letter differ, P<0.05. 
129 
 
 
Figure 5.2. High fat-fed obese mice supplemented with grape powder (GP), but not 
grape powder extract (GPE), had better glucose disposal rates acutely, but not 
chronically. Male C57BL/6J mice were fed for 18 wk a low-fat (LF) diet, a high-fat (HF) 
diet, a high-fat diet plus GPE (HFGE) diet, a high-fat diet with a modified sugar (HS) 
content similar to the HFGP group, or a high-fat diet plus GP (HFGP) diet. A-C: 
Intraperitoneal glucose tolerance test (GTT) was performed and total GTT area under the 
curve (AUC) was calculated at 5 wk (A), 10 wk (B), and 15 wk (C). The mRNA levels of 
insulin-dependent glucose transporter 4 (GLUT4) in mouse soleus skeletal muscle at 18 
wk (D) was measured using qPCR. The mRNA level of GLUT4 and adiponectin in 
mouse epididymal WAT at 18 wk (E) was measured using qPCR. Data were analyzed 
using one-way ANOVA and Student’s t tests. Means ± SEM (n=7-9) without a common 
letter differ, P<0.05. Black squares or clear bars = LF; Black diamonds or black bars = 
HF; Clear diamonds or striped bars = HFGE; Black circles or black bars = HS; Clear 
circles or striped bars = HFGP. 
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Figure 5.3. High fat-fed obese mice supplemented with grape powder (GP), but not 
grape powder extract (GPE), had lower systemic inflammation. Male C57BL/6J mice 
were fed for 18 wk a low-fat (LF) diet, a high-fat (HF) diet, a high-fat diet plus GPE 
(HFGE) diet, a high-fat diet with a modified sugar (HS) content similar to the HFGP 
group, or a high-fat diet plus GP (HFGP) diet. At 18 wk, blood was collected and serum 
was harvested to measure the levels of an inflammatory cytokine (e.g., TNFα) and 
chemokine (e.g., MCP-1). Also, WAT depots were harvested to measure the mRNA 
levels of inflammatory cytokines (e.g., TNFα, IL-6) and chemokines (e.g., MCP-1, IP-10) 
and macrophage markers (e.g., CD11c, F4/80). The concentrations (ng/L) of TNFα and 
MCP-1 in mouse serum (A) were measured using magnetic bead-multiplex immunoassay 
and enzyme-linked immunosorbent assay, respectively. The mRNA levels of TNFα, 
MCP-1, CD11c, and F4/80 in epididymal WAT (B) were measured using qPCR. The 
mRNA levels of IL-6, MCP-1, IP-10, and F4/80 in inguinal WAT (C) were measured 
using qPCR. Data were analyzed using one-way ANOVA and Student’s t tests. Means ± 
SEM (n=7-9) without a common letter differ, P<0.05. Clear bars = LF; Black bars = HF 
or HS; Striped bars = HFGE or HFGP. 
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Figure 5.4. Quercetin 3-O-glucoside (Q3G) attenuated TNFα-mediated MCP-1 and 
IL-1 β gene expression and JNK and cJun activation in primary human adipocytes. 
Cultures of newly-differentiated primary human adipocytes (d 7) were pretreated with 
DMSO vehicle (-), or 1.5 nmol/L, or 3, 10, or 30 µmol/L Q3G for 1 h and then treated 
without (-) or with 20 ng/L TNFα for 3 h to measure inflammatory gene expression or 1 h 
to measure inflammatory kinase and transcription factor activation. The mRNA level of 
MCP-1 and IL-1β (A) was measured using qPCR. The protein level of phos rylated 
JNK, total JNK, phosphorylated c-Jun, and total c-Jun (B) were determined using 
immunoblotting. Data in panel A were analyzed using one-way ANOVA and Student’s t 
tests. Means ± SEM (n=3) without a common letter differ, P<0.05. Data in panels A and 
B are representative of three independent experiments. Clear bars = DMSO vehicle 
controls; Black bars = TNFα alone; Striped bars = TNFα + Q3G. 
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CHAPTER VI 
 
EPILOGUE 
 
 
Over the past three decades, the prevalence of obesity and related diseases (e.g., 
type 2 diabetes, atherosclerosis, and hypertension), have risen dramatically in the United 
States (1). Indeed, obesity is becoming a global het  issue (1). One of the important 
mechanisms that connect obesity and insulin resistance or type 2 diabetes is the 
overexpansion of white adipose tissue (WAT) mass that leads to a chronic, low grade 
inflammation characterized by increased pro-inflammatory cytokines such as tumor 
necrosis factor alpha (TNFα; 2). Several strategies to suppress WAT overexpansion and 
obesity-mediated inflammation and insulin resistance include deceased caloric 
consumption and increased physical activity, or pharmacological and surgical 
interventions (3). However, these strategies involve long-term lifestyle changes which are 
usually poorly maintained. Furthermore, pharmacological and surgical approaches have 
potential side effects and can be expensive without a guarantee of successful long-term 
weight loss (3). Therefore, alternative strategies for decreasing obesity-associated 
inflammation and insulin resistance are needed. One potential dietary strategy is 
consuming grapes. 
Early epidemiologic data and recent intervention studies suggest that grapes and 
grape products (e.g., wine, grape juice, powder, and extracts) exert cardioprotective 
effects due to their abundant content of polyphenols such as quercetin and resveratrol that
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possess anti-oxidant and anti-inflammatory properties (4-8). However, the inhibitory 
effect of grapes and their polyphenols on obesity-mediated inflammation and insulin 
resistance remains uncertain. Specifically, the ability of grape polyphenols to attenuate 
inflammation and insulin resistance triggered by TNFα and their mechanisms of action in 
primary human adipocytes are unknown. Additionally, the bioavailability of grape 
polyphenols and their ability to reduce inflammation and insulin resistance in a diet-
induced obese animal model are unclear. Therefore, I investigated 1) the extent to which 
grape powder extract (GPE) and several of its polyphenols decrease TNFα-mediated 
inflammation and insulin resistance and their mechanisms of action in primary cultures of 
human adipocytes (CHARPTER III and IV ), and 2) the extent to which grape powder 
(GP) polyphenols are absorbed and reduce markers of inflammation and insulin 
resistance in high fat-fed obese mice (CHARPTER V ).   
Based on the results from these studies, I found that in primary cultures of newly-
differentiated human adipocytes GPE, quercetin, andto a lesser extent resveratrol 
attenuated TNFα-induced expression of inflammatory genes including interleukin (IL)-6, 
IL-1β, IL-8, and monocyte chemoattractant protein (MCP)-1, possibly by decreasing 
TNFα-mediated activation of extracellular signal-related kinase (ERK) or c-Jun NH2-
terminal kinase (JNK) and their downstream transcription factors nuclear factor-kappa B 
(NF-κB) or activator protein-1 (AP-1; i.e., c-Jun), respctively. Moreover, GPE and 
quercetin attenuated TNFα-mediated serine phosphorylation of insulin receptor substrate-
1 (IRS-1) and gene expression of protein tyrosine phos hatase (PTP)-1B, which are 
negative regulators of insulin sensitivity, and suppression of insulin-stimulated glucose 
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uptake. Notably, quercetin and resveratrol attenuated TNFα-mediated suppression of 
peroxisome proliferator-activated receptor γ (PPARγ) and PPARγ target genes and of 
PPARγ protein concentrations and transcriptional activity. I also demonstrated that 
quercetin 3-O-glucoside (Q3G) was increased in the sera of mice at 1 h post-GPE gavage 
and decreased to baseline levels within 3-8 h. GP supplementation of high fat (HF)-fed 
obese mice improved glucose disposal rate at 5 wk, but not at 10 or 15 wk. Notably, HF-
fed obese mice supplemented with GP had lower serum levels of TNFα and MCP-1 and 
mRNA levels of inflammatory-related genes (e.g., TNFα, IL-6, MCP-1, IP-10, F4/80, 
CD11c) in WAT at 18 wk. Surprisingly, GPE had no significant impact on these 
outcomes. Lastly, bioavailable Q3G attenuated TNFα-mediated MCP-1 and IL-1β gene 
expression in primary human adipocytes, possibly by suppressing the activation of JNK 
and c-Jun. 
Based on these findings, I have developed the following research questions: 1) Do 
grape polyphenol metabolites play a role in attenuati g obesity-mediated inflammation 
and insulin resistance?, 2) What role do grape anthocynins play in attenuating obesity-
mediated inflammation and insulin resistance?, and 3) Is the gut microbiota the target of 
grape components and responsible for their anti-inflammatory and anti-diabetic 
properties? 
Q1. Do grape polyphenol metabolites play a role in attenuating obesity-mediated 
inflammation and insulin resistance?  
Polyphenols are present in grapes primarily in the glycosylated form, not in the 
aglycone form. After deglycosylation, polyphenols can be glucuronidated, sulfated, or 
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methylated in small intestines, colon, liver or kidney (9). However, our bioavailability 
study did not measure any glucuronidated, sulphated, or methylated polyphenols. Thus, 
we do not know if these polyphenol metabolites were bioavailable after gavaging GPE, or 
if they contributed to GP’s suppression of insulin resistance at 5 wk, and markers of 
inflammation at 18 wk in our feeding study. However, treatment of primary human 
adipocytes with quercetin 3-O glucuronide at 1.5 nmol/L~60 µmol/L levels did not 
suppress the mRNA levels of several inflammatory genes (e.g., IL-6, IL-8, IL-1β, and 
MCP-1) induced by TNFα (data not shown); suggesting that this quercetin metabolite is 
not a major anti-inflammatory polyphenol in GP. Therefore, it will be important in the 
future to identify bioavailable polyphenol metabolites in circulation and examine their 
effect on inflammation and insulin resistance in a diet-induced obese mouse model or 
clinical studies with overweight or obese individuals supplemented with GP. 
Q2. What role do grape anthocyanins play in attenuating obesity-mediated 
inflammation and insulin resistance? 
Our data showed that anthocyanins (e.g., malvidin 3-O-glucoside and peonidin 3-
O-glucoside) were present in relatively high amounts i  our GPE and GP. However, 
anthocyanins were undetectable in our mouse serum samples within 1-8 h after GPE 
gavage. Consistent with our data, several intervention studies reported that anthocyanins 
such as malvidin 3-O-glucoside or their metabolites were undetectable or at very low 
levels in the plasma of adult subjects after a single oral administration of red wine and red 
grape juice within 0.5-2.5 h (10, 11). These findings suggest that grape anthocyanins are 
1) poorly absorbed from the intestine, 2) metabolized by the gut microbiota, or 3) rapidly 
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eliminated in the urine (12). However, in spite of the low bioavailability of grape 
anthocyanins, several health benefits of c nsuming berries (e.g. decreased obesity-
mediated inflammation and insulin resistance) have be n attributed to their anthocyanins 
(13, 14). Therefore, future studies will be needed to investigate the relationship between 
the low bioavailability of grape anthocyanins and their metabolites, and the high 
biological activity of grape anthocyanins and their metabolites in attenuating obesity-
mediated inflammation and insulin resistance. For example, identifying molecular targets 
that interact with grape anthocyanins or their metabolites would be important.  
Q3. Is gut microbiota the target of grape components and responsible for their 
anti-inflammatory and anti-diabetic properties? 
 Due to their poor absorption, grape polyphenols accumulate in the lower small 
intestine, cecum, and colon. Here, resident microbiota metabolizes polyphenols by 
deglycosylation and cleavage of ring structures, producing phenolic acids and aldehydes 
(15). These metabolites, in turn, can be absorbed or further interact with gut microbes.  
Therefore, it is conceivable that grape components like polyphenols interact with gut 
microbiota, affecting their populations and metabolic end products. Consistent with this 
concept, recent studies reported that high fat diets increase the expansion of WAT and 
subsequent inflammation and metabolic dysfunction in concert with changes in gut 
microbiota and gut barrier dysfunction (16-18). Thus, given the low bioavailability of 
grape polyphenols, it is possible that grape polyphenols or non-digestible components in 
grapes modulate gut microbiota by decreasing populations of inflammatory microbes. For 
examples, reductions in pro-inflammatory microbes in the gut such as sulphate-reducing 
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bacteria that cause mucosal barrier damage and leakag  leading to endotoxemia (i.e., 
elevated lipopolysaccharides or LPS due to translocati n of gram negative bacteria) and 
systemic inflammation, could be responsible for the beneficial effects of GP consumption 
that we observed in our high-fat feeding study. Therefore, future studies will focus on the 
interaction between polyphenols and other non-digestibl  components in grapes and 
changes in gut microbiota and barrier function to understand the mechanisms by which 
grape powder improves systemic inflammation and insul  resistance (Figure 6.1). 
In summary, further research is needed to better understand the role of 
bioavailable grape polyphenols, especially anthocyanins, and their metabolites that play 
in attenuating obesity-mediated inflammation and insulin resistance. In addition, it is 
important to understand the mechanism of action of grape components in attenuating 
intestinal inflammation and its related metabolic dseases associated with consuming a 
high fat diet. The proposed studies will provide valuable information for developing 
dietary strategies using grape products for the control of obesity-related conditions 
including inflammation and insulin resistance or type 2 diabetes. 
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Figure 6.1. Working model on how grape powder blocks obesity-mediated 
inflammatory signaling, insulin resistance, and lipodystrophy.  
LPS, lipopolysaccharides. 
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